Document
false --01-02 Q1 2020 0001359841 2.00 2.00 2.00 5000 0 0.15 0.15 0.15 0.15 0.01 0.01 0.01 2000000000 2000000000 2000000000 361471010 362449037 348035310 361471010 362449037 348035310 1205000 1272000 1658000 7280000 0.01 0.01 0.01 50000000 50000000 50000000 0 0 0 0 0 0 0001359841 2019-12-29 2020-03-28 0001359841 2020-04-24 0001359841 2018-12-30 2019-03-30 0001359841 2020-03-28 0001359841 2019-03-30 0001359841 2019-12-28 0001359841 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-28 0001359841 us-gaap:AdditionalPaidInCapitalMember 2020-03-28 0001359841 us-gaap:CommonStockMember 2020-03-28 0001359841 us-gaap:AdditionalPaidInCapitalMember 2019-12-28 0001359841 us-gaap:CommonStockMember 2019-12-29 2020-03-28 0001359841 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-28 0001359841 us-gaap:AdditionalPaidInCapitalMember 2019-12-29 2020-03-28 0001359841 us-gaap:CommonStockMember 2019-12-28 0001359841 us-gaap:RetainedEarningsMember 2019-12-29 2020-03-28 0001359841 us-gaap:RetainedEarningsMember 2020-03-28 0001359841 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-29 2020-03-28 0001359841 us-gaap:RetainedEarningsMember 2019-12-28 0001359841 us-gaap:CommonStockMember 2018-12-29 0001359841 us-gaap:CommonStockMember 2019-03-30 0001359841 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-29 0001359841 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-30 2019-03-30 0001359841 us-gaap:AdditionalPaidInCapitalMember 2018-12-30 2019-03-30 0001359841 us-gaap:RetainedEarningsMember 2019-03-30 0001359841 us-gaap:CommonStockMember 2018-12-30 2019-03-30 0001359841 us-gaap:AdditionalPaidInCapitalMember 2019-03-30 0001359841 2018-12-29 0001359841 us-gaap:RetainedEarningsMember 2018-12-30 2019-03-30 0001359841 us-gaap:AdditionalPaidInCapitalMember 2018-12-29 0001359841 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-30 0001359841 us-gaap:RetainedEarningsMember 2018-12-29 0001359841 2018-12-30 2019-12-28 0001359841 hbi:RevolvingLoanFacilityMember us-gaap:SubsequentEventMember 2020-04-28 2020-04-28 0001359841 hbi:RevolvingLoanFacilityMember 2019-12-29 2020-03-28 0001359841 us-gaap:SalesChannelDirectlyToConsumerMember 2018-12-30 2019-03-30 0001359841 hbi:ThirdpartybrickandmortarMember 2018-12-30 2019-03-30 0001359841 hbi:ThirdpartybrickandmortarMember 2019-12-29 2020-03-28 0001359841 us-gaap:SalesChannelDirectlyToConsumerMember 2019-12-29 2020-03-28 0001359841 hbi:BrasNThingsMember 2018-12-30 2019-03-30 0001359841 hbi:BrasNThingsMember 2018-02-12 0001359841 hbi:BrasNThingsMember 2017-12-31 2018-12-29 0001359841 hbi:BrasNThingsMember 2018-02-12 2018-02-12 0001359841 hbi:BrasNThingsMember 2019-06-30 2019-09-28 0001359841 us-gaap:EmployeeStockMember 2018-12-30 2019-03-30 0001359841 us-gaap:StockOptionMember 2018-12-30 2019-03-30 0001359841 us-gaap:EmployeeStockMember 2019-12-29 2020-03-28 0001359841 us-gaap:RestrictedStockUnitsRSUMember 2019-12-29 2020-03-28 0001359841 us-gaap:RestrictedStockUnitsRSUMember 2018-12-30 2019-03-30 0001359841 us-gaap:StockOptionMember 2019-12-29 2020-03-28 0001359841 hbi:A2020ShareRepurchasePlanMemberMember 2020-03-28 0001359841 hbi:A2020ShareRepurchasePlanMemberMember 2019-12-29 2020-03-28 0001359841 hbi:A2020ShareRepurchasePlanMemberMember 2020-02-06 0001359841 hbi:A2016ShareRepurchasePlanMember 2016-04-27 0001359841 hbi:A4.625SeniorNotesMember 2020-03-28 0001359841 hbi:RevolvingLoanFacilityMember 2019-12-28 0001359841 hbi:A4.875SeniorNotesMember 2020-03-28 0001359841 hbi:EuropeanRevolvingLoanFacilityMember 2019-12-28 0001359841 hbi:RevolvingLoanFacilityMember 2020-03-28 0001359841 hbi:TermLoanAMember 2020-03-28 0001359841 hbi:A4.875SeniorNotesMember 2019-12-28 0001359841 hbi:A4.625SeniorNotesMember 2019-12-28 0001359841 hbi:AccountsReceivableSecuritizationFacilityMember 2020-03-28 0001359841 hbi:A3.50SeniorNotesMember 2020-03-28 0001359841 hbi:TermLoanBMember 2019-12-28 0001359841 hbi:TermLoanBMember 2020-03-28 0001359841 hbi:EurodenominatedLongtermDebtMember hbi:A3.50SeniorNotesMember 2020-03-28 0001359841 hbi:AustralianRevolvingFacilityMember 2020-03-28 0001359841 hbi:EuropeanRevolvingLoanFacilityMember 2020-03-28 0001359841 hbi:AccountsReceivableSecuritizationFacilityMember 2019-12-28 0001359841 hbi:A3.50SeniorNotesMember 2019-12-28 0001359841 hbi:AustralianRevolvingFacilityMember 2019-12-28 0001359841 hbi:TermLoanAMember 2019-12-28 0001359841 hbi:SeniorSecuredCreditFacilityMember us-gaap:SubsequentEventMember 2021-07-03 0001359841 hbi:SeniorSecuredCreditFacilityMember us-gaap:SubsequentEventMember 2021-04-04 2021-07-03 0001359841 hbi:SeniorSecuredCreditFacilityMember us-gaap:SubsequentEventMember 2020-03-29 2020-06-27 0001359841 hbi:SeniorSecuredCreditFacilityMember 2019-12-29 2020-03-28 0001359841 srt:MinimumMember hbi:SeniorSecuredCreditFacilityMember 2020-03-28 0001359841 srt:MaximumMember hbi:SeniorSecuredCreditFacilityMember 2020-03-28 0001359841 hbi:OtherInternationalDebtMember 2020-03-28 0001359841 hbi:SeniorSecuredCreditFacilityMember us-gaap:SubsequentEventMember 2020-09-26 0001359841 hbi:SeniorSecuredCreditFacilityMember us-gaap:SubsequentEventMember 2020-06-27 0001359841 hbi:SeniorSecuredCreditFacilityMember us-gaap:SubsequentEventMember 2021-04-03 0001359841 hbi:SeniorSecuredCreditFacilityMember us-gaap:SubsequentEventMember 2021-01-02 0001359841 hbi:SeniorSecuredCreditFacilityMember us-gaap:SubsequentEventMember 2020-09-27 2021-01-02 0001359841 hbi:SeniorSecuredCreditFacilityMember us-gaap:SubsequentEventMember 2021-01-03 2021-04-03 0001359841 hbi:SeniorSecuredCreditFacilityMember us-gaap:SubsequentEventMember 2020-06-28 2020-09-26 0001359841 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-12-29 2020-03-28 0001359841 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-12-28 0001359841 us-gaap:AccumulatedTranslationAdjustmentMember 2020-03-28 0001359841 hbi:AccumulatedDefinedBenefitPlansAdjustmentBeforeTaxMember 2019-12-29 2020-03-28 0001359841 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-29 2020-03-28 0001359841 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-28 0001359841 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-03-28 0001359841 hbi:AccumulatedDefinedBenefitPlansAdjustmentBeforeTaxMember 2019-12-28 0001359841 hbi:IncometaxesMember 2019-12-29 2020-03-28 0001359841 hbi:AccumulatedDefinedBenefitPlansAdjustmentBeforeTaxMember 2020-03-28 0001359841 hbi:IncometaxesMember 2019-12-28 0001359841 hbi:IncometaxesMember 2020-03-28 0001359841 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember hbi:AccumulatedDefinedBenefitPlansAdjustmentBeforeTaxMember 2018-12-30 2019-03-30 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-12-29 2020-03-28 0001359841 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2018-12-30 2019-03-30 0001359841 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember hbi:AccumulatedDefinedBenefitPlansAdjustmentBeforeTaxMember 2019-12-29 2020-03-28 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-12-30 2019-03-30 0001359841 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-12-29 2020-03-28 0001359841 us-gaap:ForeignExchangeContractMember 2018-12-30 2019-03-30 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2019-12-29 2020-03-28 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-12-29 2020-03-28 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-12-30 2019-03-30 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2018-12-30 2019-03-30 0001359841 us-gaap:ForeignExchangeContractMember 2019-12-29 2020-03-28 0001359841 us-gaap:CurrencySwapMember us-gaap:InterestExpenseMember 2018-12-30 2019-03-30 0001359841 us-gaap:CurrencySwapMember us-gaap:InterestExpenseMember 2019-12-29 2020-03-28 0001359841 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-12-28 0001359841 us-gaap:LiabilitiesTotalMember 2019-12-28 0001359841 us-gaap:LiabilitiesTotalMember 2020-03-28 0001359841 us-gaap:AssetsTotalMember 2020-03-28 0001359841 hbi:OtherCurrentAssetMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-28 0001359841 hbi:OtherCurrentAssetMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-03-28 0001359841 us-gaap:OtherNoncurrentAssetsMember us-gaap:CurrencySwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-28 0001359841 us-gaap:OtherNoncurrentAssetsMember us-gaap:CurrencySwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-28 0001359841 hbi:OtherCurrentAssetMember us-gaap:CurrencySwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-28 0001359841 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-28 0001359841 hbi:OtherCurrentAssetMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-12-28 0001359841 hbi:OtherCurrentAssetMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-28 0001359841 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-03-28 0001359841 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-28 0001359841 hbi:OtherCurrentAssetMember us-gaap:CurrencySwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-28 0001359841 us-gaap:AssetsTotalMember 2019-12-28 0001359841 hbi:EurodenominatedLongtermDebtMember hbi:A3.50SeniorNotesMember 2019-07-10 2019-07-10 0001359841 us-gaap:CurrencySwapMember 2019-07-10 0001359841 us-gaap:ForeignExchangeContractMember 2020-03-28 0001359841 hbi:EurodenominatedLongtermDebtMember hbi:A3.50SeniorNotesMember 2019-12-29 2020-03-28 0001359841 us-gaap:CurrencySwapMember 2020-03-28 0001359841 hbi:A4.625SeniorNotesMember us-gaap:CurrencySwapMember 2020-03-28 0001359841 us-gaap:CurrencySwapMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-30 2019-03-30 0001359841 us-gaap:CurrencySwapMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-29 2020-03-28 0001359841 hbi:EurodenominatedLongtermDebtMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-29 2020-03-28 0001359841 hbi:EurodenominatedLongtermDebtMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-30 2019-03-30 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-28 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-28 0001359841 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-28 0001359841 us-gaap:FairValueMeasurementsRecurringMember 2020-03-28 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-28 0001359841 us-gaap:CurrencySwapMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-28 0001359841 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-28 0001359841 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-28 0001359841 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-28 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-28 0001359841 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-28 0001359841 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-28 0001359841 us-gaap:FairValueInputsLevel2Member 2020-03-28 0001359841 us-gaap:FairValueInputsLevel2Member 2019-12-28 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-28 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-28 0001359841 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-28 0001359841 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-28 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-28 0001359841 us-gaap:FairValueMeasurementsRecurringMember 2019-12-28 0001359841 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-28 0001359841 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-28 0001359841 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-28 0001359841 us-gaap:CurrencySwapMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-28 0001359841 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-28 0001359841 us-gaap:CurrencySwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-28 0001359841 hbi:DiscretebenefitMember 2018-12-30 2019-03-30 0001359841 hbi:TotalMember 2018-12-30 2019-03-30 0001359841 us-gaap:CostOfSalesMember 2019-12-29 2020-03-28 0001359841 us-gaap:CostOfSalesMember 2018-12-30 2019-03-30 0001359841 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-12-29 2020-03-28 0001359841 us-gaap:AccruedLiabilitiesMember 2020-03-28 0001359841 hbi:TotalMember 2019-12-29 2020-03-28 0001359841 us-gaap:OtherNoncurrentLiabilitiesMember 2020-03-28 0001359841 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-12-30 2019-03-30 0001359841 hbi:OperatingSegmentMember 2019-12-29 2020-03-28 0001359841 hbi:InternationalMember 2018-12-30 2019-03-30 0001359841 hbi:ActivewearMember 2018-12-30 2019-03-30 0001359841 hbi:InnerwearMember 2019-12-29 2020-03-28 0001359841 us-gaap:CorporateNonSegmentMember 2018-12-30 2019-03-30 0001359841 hbi:ActivewearMember 2019-12-29 2020-03-28 0001359841 hbi:OperatingSegmentMember 2018-12-30 2019-03-30 0001359841 us-gaap:CorporateNonSegmentMember 2019-12-29 2020-03-28 0001359841 hbi:InnerwearMember 2018-12-30 2019-03-30 0001359841 hbi:InternationalMember 2019-12-29 2020-03-28 0001359841 hbi:AsRevisedMember 2019-06-29 0001359841 srt:ScenarioPreviouslyReportedMember 2018-12-30 2019-06-29 0001359841 srt:RestatementAdjustmentMember 2019-06-29 0001359841 srt:ScenarioPreviouslyReportedMember 2019-06-29 0001359841 srt:RestatementAdjustmentMember 2018-12-30 2019-06-29 0001359841 srt:RestatementAdjustmentMember 2018-12-29 0001359841 hbi:AsRevisedMember 2018-12-29 0001359841 hbi:AsRevisedMember 2018-12-30 2019-06-29 0001359841 srt:ScenarioPreviouslyReportedMember 2018-12-29 0001359841 srt:RestatementAdjustmentMember 2019-06-30 2019-09-28 0001359841 srt:ScenarioPreviouslyReportedMember 2019-06-30 2019-09-28 0001359841 hbi:AsRevisedMember 2019-06-30 2019-09-28 0001359841 srt:ScenarioPreviouslyReportedMember 2019-03-30 0001359841 srt:ScenarioPreviouslyReportedMember 2019-03-31 2019-06-29 0001359841 hbi:AsRevisedMember 2019-03-31 2019-06-29 0001359841 srt:RestatementAdjustmentMember 2019-03-30 0001359841 srt:RestatementAdjustmentMember 2019-03-31 2019-06-29 0001359841 hbi:AsRevisedMember 2019-03-30 0001359841 srt:RestatementAdjustmentMember 2018-12-30 2019-09-28 0001359841 srt:ScenarioPreviouslyReportedMember 2018-12-30 2019-09-28 0001359841 hbi:AsRevisedMember 2018-12-30 2019-09-28 0001359841 srt:ScenarioPreviouslyReportedMember 2018-12-30 2019-03-30 0001359841 hbi:AsRevisedMember 2018-12-30 2019-03-30 0001359841 srt:RestatementAdjustmentMember 2018-12-30 2019-03-30 0001359841 hbi:AsRevisedMember 2019-09-28 0001359841 srt:RestatementAdjustmentMember 2019-09-28 0001359841 srt:ScenarioPreviouslyReportedMember 2019-09-28 xbrli:pure iso4217:USD xbrli:shares iso4217:AUD iso4217:USD iso4217:EUR xbrli:shares

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
 
FORM 10-Q
 
 
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 28, 2020
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                     to                     
Commission file number: 001-32891
 
 
 
Hanesbrands Inc.
(Exact name of registrant as specified in its charter)
 
 
 
Maryland
 
20-3552316
(State of incorporation)
 
(I.R.S. employer identification no.)
 
 
 
1000 East Hanes Mill Road
 

Winston-Salem,
North Carolina
 
27105
(Address of principal executive office)
 
(Zip code)
( 336 ) 519-8080
(Registrant’s telephone number including area code)
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes         No   
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).     Yes         No   
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer
 
 
Accelerated filer
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-accelerated filer
 
 
Smaller reporting company
 
 
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes         No   
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol
Name of each exchange on which registered
Common Stock, Par Value $0.01
HBI
New York Stock Exchange
As of April 24, 2020 , there were 348,035,310 shares of the registrant’s common stock outstanding.
 



TABLE OF CONTENTS
 
 
 
Page
 
 
 
 
 
Item 1.
 
 
 
 
 
 
 
Item 2.
Item 3.
Item 4.
 
 
 
PART II
 
 
Item 1.
Item 1A.
Item 2.
Item 3.
Item 4.
Item 5.
Item 6.




FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q contains information that may constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”). Forward-looking statements include all statements that do not relate solely to historical or current facts, and can generally be identified by the use of words such as “may,” “believe,” “will,” “expect,” “project,” “estimate,” “intend,” “anticipate,” “plan,” “continue” or similar expressions. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking. All statements regarding our intent, belief and current expectations about our strategic direction, prospects and future results are forward-looking statements. Management believes that these forward-looking statements are reasonable as and when made. However, caution should be taken not to place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from our historical experience and our present expectations or projections. In particular, statements with respect to trends associated with our business, our future financial performance and the potential effects of the global COVID-19 coronavirus outbreak included in this Quarterly Report on Form 10-Q specifically appearing under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” include forward-looking statements.
More information on factors that could cause actual results or events to differ materially from those anticipated is included from time to time in our reports filed with the Securities and Exchange Commission (the “SEC”), including this Quarterly Report on Form 10-Q and our Annual Report on Form 10-K for the year ended December 28, 2019 , under the caption “Risk Factors,” and available on the “Investors” section of our corporate website, www.Hanes.com/investors . The contents of our corporate website are not incorporated by reference in this Quarterly Report on Form 10-Q.

1


PART I

Item 1.
Financial Statements

HANESBRANDS INC.
Condensed Consolidated Statements of Income
(in thousands, except per share amounts)
(unaudited)

 
Quarters Ended
 
March 28,
2020
 
March 30,
2019
Net sales
$
1,316,462

 
$
1,588,024

Cost of sales
842,730

 
967,993

Gross profit
473,732

 
620,031

Selling, general and administrative expenses
439,602

 
470,387

Operating profit
34,130

 
149,644

Other expenses
6,490

 
7,451

Interest expense, net
36,849

 
48,059

Income (loss) before income tax expense
( 9,209
)
 
94,134

Income tax expense (benefit)
( 1,335
)
 
13,046

Net income (loss)
$
( 7,874
)
 
$
81,088

 
 
 
 
Earnings (loss) per share:
 
 
 
Basic
$
( 0.02
)
 
$
0.22

Diluted
$
( 0.02
)
 
$
0.22



See accompanying notes to Condensed Consolidated Financial Statements.
2


HANESBRANDS INC.
Condensed Consolidated Statements of Comprehensive Income
(in thousands)
(unaudited)

 
Quarters Ended
 
March 28,
2020
 
March 30,
2019
Net income (loss)
$
( 7,874
)
 
$
81,088

Other comprehensive income (loss):
 
 
 
Translation adjustments
( 117,154
)
 
7,386

Unrealized gain (loss) on qualifying cash flow hedges, net of tax of $(7,280) and $1,658, respectively
7,783

 
( 3,919
)
Unrecognized income from pension and postretirement plans, net of tax of $(1,272) and $(1,205), respectively
3,594

 
3,397

Total other comprehensive income (loss)
( 105,777
)
 
6,864

Comprehensive income (loss)
$
( 113,651
)
 
$
87,952



See accompanying notes to Condensed Consolidated Financial Statements.
3


HANESBRANDS INC.
Condensed Consolidated Balance Sheets
(in thousands, except share and per share amounts)
(unaudited)

 
March 28,
2020
 
December 28,
2019
 
March 30,
2019
Assets
 
 
 
 
 
Cash and cash equivalents
$
1,083,780

 
$
328,876

 
$
287,080

Trade accounts receivable, net
725,092

 
815,210

 
932,875

Inventories
1,963,757

 
1,905,845

 
2,232,719

Other current assets
178,244

 
174,634

 
189,012

Total current assets
3,950,873

 
3,224,565

 
3,641,686

Property, net
571,005

 
587,896

 
601,689

Right-of-use assets
473,936

 
487,787

 
484,453

Trademarks and other identifiable intangibles, net
1,435,356

 
1,520,800

 
1,547,718

Goodwill
1,205,195

 
1,235,711

 
1,240,652

Deferred tax assets
188,004

 
203,331

 
213,728

Other noncurrent assets
118,890

 
93,896

 
94,233

Total assets
$
7,943,259

 
$
7,353,986

 
$
7,824,159

 
 
 
 
 
 
Liabilities and Stockholders’ Equity
 
 
 
 
 
Accounts payable
$
925,417

 
$
959,006

 
$
1,007,420

Accrued liabilities
447,401

 
531,184

 
568,450

Lease liabilities
150,568

 
166,091

 
140,435

Notes payable
2,170

 
4,244

 
5,753

Accounts Receivable Securitization Facility
152,153

 

 
200,000

Current portion of long-term debt
111,359

 
110,914

 
276,815

Total current liabilities
1,789,068

 
1,771,439

 
2,198,873

Long-term debt
4,236,955

 
3,256,870

 
3,615,493

Lease liabilities - noncurrent
358,848

 
358,281

 
373,365

Pension and postretirement benefits
375,511

 
403,458

 
352,069

Other noncurrent liabilities
309,306

 
327,343

 
351,368

Total liabilities
7,069,688

 
6,117,391

 
6,891,168

 
 
 
 
 
 
Stockholders’ equity:
 
 
 
 
 
Preferred stock (50,000,000 authorized shares; $.01 par value)
 
 
 
 
 
Issued and outstanding — None

 

 

Common stock (2,000,000,000 authorized shares; $.01 par value)
 
 
 
 
 
Issued and outstanding — 348,035,310, 362,449,037 and 361,471,010, respectively
3,480

 
3,624

 
3,615

Additional paid-in capital
297,456

 
304,395

 
306,084

Retained earnings
1,296,060

 
1,546,224

 
1,191,111

Accumulated other comprehensive loss
( 723,425
)
 
( 617,648
)
 
( 567,819
)
Total stockholders’ equity
873,571

 
1,236,595

 
932,991

Total liabilities and stockholders’ equity
$
7,943,259

 
$
7,353,986

 
$
7,824,159




See accompanying notes to Condensed Consolidated Financial Statements.
4


HANESBRANDS INC.
Condensed Consolidated Statements of Stockholders’ Equity
(dollars and shares in thousands, except per share data)
(unaudited)

 
Common Stock
 
Additional Paid-In Capital
 
Retained Earnings
 
Accumulated Other Comprehensive Loss
 
Total
 
Shares
 
Amount
 
Balances at December 28, 2019
362,449

 
$
3,624

 
$
304,395

 
$
1,546,224

 
$
( 617,648
)
 
$
1,236,595

Net loss

 

 

 
( 7,874
)
 

 
( 7,874
)
Dividends ($0.15 per common share)

 

 

 
( 54,421
)
 

 
( 54,421
)
Other comprehensive loss

 

 

 

 
( 105,777
)
 
( 105,777
)
Stock-based compensation

 

 
4,641

 

 

 
4,641

Net exercise of stock options, vesting of restricted stock units and other
50

 
1

 
675

 

 

 
676

Share repurchases
( 14,464
)
 
( 145
)
 
( 12,255
)
 
( 187,869
)
 

 
( 200,269
)
Balances at March 28, 2020
348,035

 
$
3,480

 
$
297,456

 
$
1,296,060

 
$
( 723,425
)
 
$
873,571


 
Common Stock
 
Additional Paid-In Capital
 
Retained Earnings
 
Accumulated Other Comprehensive Loss
 
Total
 
Shares
 
Amount
 
Balances at December 29, 2018
361,330

 
$
3,613

 
$
284,877

 
$
1,079,503

 
$
( 495,867
)
 
$
872,126

Net income

 

 

 
81,088

 

 
81,088

Dividends ($0.15 per common share)

 

 

 
( 54,852
)
 

 
( 54,852
)
Other comprehensive income

 

 

 

 
6,864

 
6,864

Stock-based compensation

 

 
5,057

 

 

 
5,057

Net exercise of stock options, vesting of restricted stock units and other
141

 
2

 
1,776

 

 

 
1,778

Modification of deferred compensation plans

 

 
14,374

 

 

 
14,374

Cumulative effect of change in adoption of leases standard

 

 

 
6,556

 

 
6,556

Stranded tax related to U.S. pension plan

 

 

 
78,816

 
( 78,816
)
 

Balances at March 30, 2019
361,471

 
$
3,615

 
$
306,084

 
$
1,191,111

 
$
( 567,819
)
 
$
932,991



See accompanying notes to Condensed Consolidated Financial Statements.
5


HANESBRANDS INC.
Condensed Consolidated Statements of Cash Flows
(in thousands)
(unaudited)

 
Quarters Ended
 
March 28,
2020
 
March 30,
2019
Operating activities:
 
 
 
Net income (loss)
$
( 7,874
)
 
$
81,088

Adjustments to reconcile net income (loss) to net cash from operating activities:
 
 
 
Depreciation
22,781

 
22,854

Amortization of acquisition intangibles
6,113

 
6,290

Other amortization
2,477

 
3,090

Amortization of debt issuance costs
2,123

 
2,440

Stock compensation expense
4,723

 
5,178

Deferred taxes
( 461
)
 
( 3,854
)
Other
( 9,520
)
 
4,247

Changes in assets and liabilities:
 
 
 
Accounts receivable
73,694

 
( 62,278
)
Inventories
( 86,785
)
 
( 178,405
)
Other assets
26,790

 
( 32,372
)
Accounts payable
( 13,605
)
 
( 18,213
)
Accrued pension and postretirement benefits
( 21,481
)
 
( 21,978
)
Accrued liabilities and other
( 82,191
)
 
( 2,378
)
Net cash from operating activities
( 83,216
)
 
( 194,291
)
Investing activities:
 
 
 
Capital expenditures
( 25,759
)
 
( 25,269
)
Proceeds from sales of assets
66

 
136

Other
1,216

 

Net cash from investing activities
( 24,477
)
 
( 25,133
)
Financing activities:
 
 
 
Borrowings on notes payable
62,312

 
82,774

Repayments on notes payable
( 64,352
)
 
( 82,759
)
Borrowings on Accounts Receivable Securitization Facility
227,061

 
106,942

Repayments on Accounts Receivable Securitization Facility
( 74,909
)
 
( 68,550
)
Borrowings on Revolving Loan Facilities
1,638,000

 
772,500

Repayments on Revolving Loan Facilities
( 688,000
)
 
( 680,500
)
Repayments on Term Loan Facilities

 
( 10,625
)
Borrowings on International Debt
31,222

 
7,141

Share repurchases
( 200,269
)
 

Cash dividends paid
( 53,683
)
 
( 54,221
)
Payments to amend and refinance credit facilities
( 232
)
 
( 662
)
Taxes paid related to net shares settlement of equity awards
( 62
)
 
( 906
)
Other
426

 
573

Net cash from financing activities
877,514

 
71,707

Effect of changes in foreign exchange rates on cash
( 15,061
)
 
2,104

Change in cash, cash equivalents and restricted cash
754,760

 
( 145,613
)
Cash, cash equivalents and restricted cash at beginning of year
329,923

 
455,732

Cash, cash equivalents and restricted cash at end of period
1,084,683

 
310,119

Less restricted cash at end of period
903

 
23,039

Cash and cash equivalents per balance sheet at end of period
$
1,083,780

 
$
287,080


Capital expenditures included in accounts payable at March 28, 2020 and December 28, 2019 , were $ 12,807 and $ 19,327 , respectively. At March 28, 2020 and March 30, 2019 , right-of-use assets obtained in exchange for lease obligations were $ 17,551 and $ 6,192 , respectively.

See accompanying notes to Condensed Consolidated Financial Statements.
6

HANESBRANDS INC.
Notes to Condensed Consolidated Financial Statements
(amounts in thousands, except per share data)
(unaudited)



(1)
Basis of Presentation
These statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and, in accordance with those rules and regulations, do not include all information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Management believes that the disclosures made are adequate for a fair statement of the results of operations, financial condition and cash flows of Hanesbrands Inc. and its consolidated subsidiaries (the “Company” or “Hanesbrands”). In the opinion of management, the condensed consolidated interim financial statements reflect all adjustments, which consist only of normal recurring adjustments, necessary to state fairly the results of operations, financial condition and cash flows for the interim periods presented herein. The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make use of estimates and assumptions that affect the reported amounts and disclosures. Actual results may vary from these estimates.
These condensed consolidated interim financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s 2019 Annual Report on Form 10-K. The year-end condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP. The results of operations for any interim period are not necessarily indicative of the results of operations to be expected for the full year.
Liquidity and Impact of COVID-19
The Company relies on its cash flows generated from operations and the borrowing capacity under its credit facilities to meet the cash requirements of its business. The primary cash requirements of its business are payments to employees and vendors in the normal course of business, capital expenditures, maturities of debt and related interest payments, business acquisitions, contributions to its pension plans, repurchases of its stock, regular quarterly dividend payments and income tax payments. The rapid expansion of the COVID-19 global pandemic has resulted in a sharp decline in net sales and earnings in the first quarter of 2020, which has a corresponding impact on the Company’s liquidity. The Company is focused on preserving its liquidity and managing its cash flow during these unprecedented conditions with preemptive actions to enhance its ability to meet its short-term liquidity needs. Such actions include, but are not limited to, operating manufacturing and distribution facilities on a demand-adjusted basis; reducing discretionary spending such as media and marketing expenses; focused working capital management; reducing capital expenditures; suspending its share buyback program until further notice; reducing payroll costs, through employee furloughs and pay cuts; drawing down on its Revolving Loan Facility and amending certain existing debt facilities.
In March 2020, in response to the uncertainty of the circumstances surrounding the COVID-19 global pandemic, the Company drew down $ 630,000 under the Revolving Loan Facility as a precautionary measure, to provide the Company with additional financial flexibility to manage its business with a safety-first emphasis during the unknown duration and impact of the COVID-19 global pandemic. The Company subsequently repaid $ 490,000 of its borrowings under the Revolving Loan Facility in April 2020.
As of March 28, 2020 , the Company was in compliance with all financial covenants under its credit facilities and other outstanding indebtedness. In April 2020, given the rapidly changing environment and level of uncertainty being created by the COVID-19 global pandemic and the associated impact on future earnings, the Company amended its Senior Secured Credit Facility (as discussed in Note, “Debt and Notes Payable”) prior to any potential covenant violation in order to modify the financial covenants and to provide operating flexibility during the COVID-19 crisis. After obtaining the debt amendment, which provides relief from certain covenants for a 15-month period and adds additional financial and non-financial covenants, the Company expects to maintain compliance with its covenants for at least one year from the issuance of these financial statements based on its current expectations and forecasts. If economic conditions caused by the COVID-19 global pandemic worsen and the Company’s earnings and operating cash flows do not start to recover as currently estimated by management, this could impact the Company’s ability to maintain compliance with its amended financial covenants and require the Company to seek additional amendments to its Senior Secured Credit Facility. If the Company is not able to obtain such necessary additional amendments, this would lead to an event of default and, if not cured timely, its lenders could require the Company to repay its outstanding debt. In that situation, the Company may not be able to raise sufficient debt or equity capital, or divest assets, to refinance or repay the lenders.

7

HANESBRANDS INC.
Notes to Condensed Consolidated Financial Statements — (Continued)
(amounts in thousands, except per share data)
(unaudited)

Revisions of Previously Issued Consolidated Financial Statements
As previously disclosed in the Company's Annual Report on Form 10-K for the year ended December 28, 2019, during the fourth quarter of 2019 the Company identified tax errors, which originated prior to 2017, in its previously issued 2018 and 2017 annual consolidated financial statements and quarterly condensed consolidated interim financial statements for each of the quarterly periods of 2018 and the first three quarterly periods of 2019. Although the Company assessed the materiality of the errors and concluded that the errors were not material to the previously issued annual or interim financial statements, the Company did revise its previously issued 2018 and 2017 annual financial statements to correct for such tax errors in connection with the filing of its 2019 Annual Report on Form 10-K, and disclosed that it would be revising its 2019 condensed consolidated interim financial statements in connection with the filing of its Quarterly Reports on Form 10-Q during 2020. In connection with such revision, the Company also corrected for certain other immaterial errors. In connection with the filing of this Quarterly Report on Form 10-Q, the Company has revised the accompanying condensed consolidated interim financial statements as of and for the quarter ended March 30, 2019 to correct for the impact of such errors, including the impact to retained earnings as of March 30, 2019 to correct for the errors which originated in periods prior to 2019, which primarily related to the tax errors. The accompanying footnotes have also been corrected to reflect the impact of the revisions of the previously filed condensed consolidated interim financial statements.
Additionally, in connection with the filing of this Quarterly Report on Form 10-Q, the Company has disclosed the impact of the revisions to the condensed consolidated interim financial statements as of and for the periods ended June 29, 2019 and September 28, 2019 to correct for the impact of such errors. The Company will effect the revision of its unaudited condensed consolidated interim financial statements as of and for the periods ended June 29, 2019 and September 28, 2019 with the future filings of its Quarterly Reports on Form 10-Q for the periods ended June 27, 2020 and September 26, 2020. See Note, "Revisions of Previously Issued Condensed Consolidated Interim Financial Statements," for reconciliations between as reported and as revised amounts as of and for the periods ended March 30, 2019, June 29, 2019 and September 28, 2019.
(2)
Recent Accounting Pronouncements
Financial Instruments - Credit Losses
In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” which requires a financial asset measured at amortized cost basis to be presented at the net amount expected to be collected. The new accounting rules eliminate the probable initial recognition threshold and, instead, reflect an entity’s current estimate of all expected credit losses. The new accounting rules were effective for the Company in the first quarter of 2020 and applies to its trade receivables.
Under the new accounting rules, trade receivables are now evaluated on a collective (pool) basis and aggregated on the basis of similar risk characteristics. These classifications will be reassessed at each measurement date. A combination of factors, such as industry trends, customers’ financial strength, credit standing and payment and default history are considered in determining the appropriate estimate of expected credit losses. The adoption of the new accounting rules did not have a material impact on the Company’s financial condition, results of operations or cash flows.
Goodwill Impairment
In January 2017, the FASB issued ASU 2017-04, “Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment.” The new accounting rules simplify how an entity is required to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test which previously measured a goodwill impairment loss by comparing the implied fair value of a reporting unit’s goodwill with the carrying amount. The new accounting rules were effective for the Company in the first quarter of 2020. As a result of adopting the new rules, the Company will compare the estimated fair value of its reporting units to their respective carrying values when evaluating the recoverability of goodwill. If the carrying value of a reporting unit exceeds its fair value, an impairment charge will be recognized for the amount by which its carrying value exceeds the reporting unit’s fair value; however, the loss recognized will not exceed the goodwill allocated to the reporting unit. The adoption of the new accounting rules did not have an impact on the Company’s financial condition, results of operations or cash flows.

8

HANESBRANDS INC.
Notes to Condensed Consolidated Financial Statements — (Continued)
(amounts in thousands, except per share data)
(unaudited)

Fair Value
In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820),” which modifies the disclosure requirements on fair value measurements. The new accounting rules were effective for the Company in the first quarter of 2020. The adoption of the new accounting rules did not have a material impact on the Company’s financial condition, results of operations or cash flows; however, its disclosures were updated upon adoption.
Retirement Benefits
In August 2018, the FASB issued ASU 2018-14, “Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20).” The new accounting rules expand disclosure requirements for employer sponsored defined benefit pension and other retirement plans. The new accounting rules were effective for the Company in the first quarter of 2020. The new accounting rules did not have a material impact on the Company’s financial condition, results of operations or cash flows; however, expanded disclosures will be required on the Company’s Annual Report on Form 10-K for the year ended January 2, 2021.
Internal-Use Software
In August 2018, the FASB issued ASU 2018-15, “Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 340-40),” which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The new accounting rules were effective for the Company in the first quarter of 2020. The adoption of the new accounting rules did not have a material impact on the Company’s financial condition, results of operations or cash flows.
Codification Improvements to Financial Instruments
In March 2020, the FASB issued ASU 2020-03, “Codification Improvements to Financial Instruments.” The new accounting rules clarify guidance around several subtopics by adopting enhanced verbiage to the following subtopics: fair value option disclosures, fair value measurement, investments - debt and equities securities, debt modifications and extinguishments, credit losses, and sales of financial assets. The standard was effective for the Company in the first quarter of 2020. The adoption of the new accounting rules did not have a material impact on the Company’s results of operations or cash flows.
Income Taxes
In December 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.” The new accounting rules reduce complexity by removing specific exceptions to general principles related to intraperiod tax allocations, ownership changes in foreign investments, and interim period income tax accounting for year-to-date losses that exceed anticipated losses. The new accounting rules also simplify accounting for franchise taxes that are partially based on income, transactions with a government that result in a step up in the tax basis of goodwill, separate financial statements of legal entities that are not subject to tax, and enacted changes in tax laws in interim periods. The new accounting rules will be effective for the Company in the first quarter of 2021. The Company is currently in the process of evaluating the impact of adoption of the new accounting rules on the Company’s financial condition, results of operations, cash flows and disclosures.
Reference Rate Reform
In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The new accounting rules provide optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by reference rate reform. The amendments in this standard can be applied anytime between the first quarter of 2020 and the fourth quarter of 2022. The Company is currently in the process of evaluating the impact of adoption of the new rules on the Company’s financial condition, results of operations, cash flows and disclosures.

9

HANESBRANDS INC.
Notes to Condensed Consolidated Financial Statements — (Continued)
(amounts in thousands, except per share data)
(unaudited)

(3)
Revenue Recognition
Revenue is recognized when obligations under the terms of a contract with a customer are satisfied, which occurs at a point in time, upon either shipment or delivery to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods, which includes estimates for variable consideration. Variable consideration includes trade discounts, rebates, volume-based incentives, cooperative advertising and product returns, which are offered within contracts between the Company and its customers, employing the practical expedient for contract costs. Incidental items that are immaterial to the context of the contract are recognized as expense at the transaction date.
The following table presents the Company’s revenues disaggregated by the customer’s method of purchase:
 
Quarters Ended
 
March 28,
2020
 
March 30,
2019
Third-party brick-and-mortar wholesale
$
978,127

 
$
1,231,423

Consumer-directed
338,335

 
356,601

Total net sales
$
1,316,462

 
$
1,588,024


Revenue Sources
Third-Party Brick-and-Mortar Wholesale Revenue
Third-party brick-and-mortar wholesale revenue is primarily generated by sales of the Company’s products to retailers to support their brick-and-mortar operations. Also included within third-party brick-and-mortar wholesale revenues is royalty revenue from licensing agreements. The Company earns royalties through license agreements with manufacturers of other consumer products that incorporate certain of the Company’s brands. The Company accrues revenue earned under these contracts based upon reported sales from the licensees.
Consumer-Directed Revenue
Consumer-directed revenue is primarily generated through sales driven directly by the consumer through company-operated stores and e-commerce platforms, which include both owned sites and the sites of the Company’s retail customers.
(4)
Acquisitions
Bras N Things
On February 12, 2018, the Company acquired 100 % of the outstanding equity of BNT Holdco Pty Limited (“Bras N Things”) for a total purchase price of A $ 498,236 (U.S. $ 391,572 ). During 2018, due to the final working capital adjustment, the purchase consideration was reduced by A$ 3,012 (U.S. $ 2,367 ), ultimately resulting in a revised purchase price of A$ 495,224 (U.S. $ 389,205 ), which included a cash payment of A $ 428,956 (U.S. $ 337,123 ), an indemnification escrow of A $ 31,988 (U.S. $ 25,140 ) and debt assumed of A $ 34,280 (U.S. $ 26,942 ). U.S. dollar equivalents are based on acquisition date exchange rates.
The Company funded the acquisition with a combination of short-term borrowings under its existing revolving loan facility (the “Revolving Loan Facility”) and cash on hand. During the third quarter of 2019, A $ 31,425 (U.S. $ 21,360 ) of the indemnification escrow, including interest earned, was paid to the sellers. The remaining indemnification escrow, held in one of the Company’s bank accounts, is recognized and classified as restricted cash, with the balance as of March 28, 2020 included in the “Other current assets” line of the Condensed Consolidated Balance Sheet.
Since February 12, 2018, goodwill related to the Bras N Things acquisition decreased by $ 792 as a result of measurement period adjustments, primarily related to working capital adjustments. The purchase price allocation was finalized in the first quarter of 2019.

10

HANESBRANDS INC.
Notes to Condensed Consolidated Financial Statements — (Continued)
(amounts in thousands, except per share data)
(unaudited)

(5)
Stockholders’ Equity
Basic earnings per share (“EPS”) was computed by dividing net income by the number of weighted average shares of common stock outstanding during the period. Diluted EPS was calculated to give effect to all potentially issuable dilutive shares of common stock using the treasury stock method.
The reconciliation of basic to diluted weighted average shares outstanding is as follows:
 
Quarters Ended
 
March 28,
2020
 
March 30,
2019
Basic weighted average shares outstanding
359,017

 
364,570

Effect of potentially dilutive securities:
 
 
 
Stock options

 
471

Restricted stock units

 
254

Employee stock purchase plan and other

 
4

Diluted weighted average shares outstanding
359,017

 
365,299


For the quarter ended March 28, 2020, all potentially dilutive securities were excluded from the diluted earnings per share calculation because the Company incurred a net loss for this period and their inclusion would be anti-dilutive. Anti-dilutive securities excluded from the diluted earnings per share calculation for the quarter ended March 28, 2020 are not material. For the quarter ended March 30, 2019 , restricted stock units totaling five were excluded from the diluted earnings per share calculation because their effect would be anti-dilutive. For the quarter ended March 30, 2019 , there were no anti-dilutive stock options to purchase shares of common stock.
On February 6, 2020 , the Company’s Board of Directors approved a new share repurchase program for up to 40,000 shares to be repurchased in open market transactions, subject to market conditions, legal requirements and other factors. Additionally, management has been granted authority to establish a trading plan under Rule 10b5-1 of the Exchange Act in connection with share repurchases, which will allow the Company to repurchase shares in the open market during periods in which the stock trading window is otherwise closed for the Company and certain of the Company’s officers and employees pursuant to the Company’s insider trading policy. Unless terminated earlier by the Company’s Board of Directors, the new program will expire when the Company has repurchased all shares authorized for repurchase under the new program. The new program replaced the Company’s previous share repurchase program for up to 40,000 shares that was originally approved in 2016. For the quarter ended March 28, 2020 , the Company entered into transactions to repurchase 14,464 shares at a weighted average repurchase price of $ 13.83 per share under the new program. The shares were repurchased at a total cost of $ 200,269 . The Company did not repurchase any shares under the previous share repurchase program during the quarter ended March 28, 2020 or March 30, 2019 . At March 28, 2020 , the remaining repurchase authorization under the current share repurchase program totaled 25,536 shares. The primary objective of the share repurchase program is to utilize excess cash to generate shareholder value.
(6)
Inventories
Inventories consisted of the following:  
 
March 28,
2020
 
December 28,
2019
 
March 30,
2019
Raw materials
$
89,558

 
$
83,545

 
$
118,824

Work in process
124,725

 
136,592

 
170,746

Finished goods
1,749,474

 
1,685,708

 
1,943,149

 
$
1,963,757

 
$
1,905,845

 
$
2,232,719



11

HANESBRANDS INC.
Notes to Condensed Consolidated Financial Statements — (Continued)
(amounts in thousands, except per share data)
(unaudited)

(7)
Debt and Notes Payable
Debt and notes payable consisted of the following:  
 
Interest
Rate as of
March 28,
2020
 
Principal Amount
 
Maturity Date
 
March 28,
2020
 
December 28,
2019
 
Senior Secured Credit Facility:
 
 
 
 
 
 
 
Revolving Loan Facility
1.91 %
 
$
950,000

 
$

 
December 2022
Term Loan A
1.89 %
 
625,000

 
625,000

 
December 2022
Term Loan B
3.35 %
 
300,000

 
300,000

 
December 2024
Australian Revolving Loan Facility
1.67 %
 
30,817

 

 
July 2021
4.875% Senior Notes
4.88 %
 
900,000

 
900,000

 
May 2026
4.625% Senior Notes
4.63 %
 
900,000

 
900,000

 
May 2024
3.5% Senior Notes
3.50 %
 
556,793

 
558,847

 
June 2024
European Revolving Loan Facility
1.50 %
 
111,359

 
110,914

 
September 2020
Accounts Receivable Securitization Facility
2.20 %
 
152,153

 

 
March 2021
Total debt
 
 
4,526,122

 
3,394,761

 
 
Notes payable
 
 
2,170

 
4,244

 
 
Total debt and notes payable
 
 
4,528,292

 
3,399,005

 
 
Less long-term debt issuance costs
 
 
25,655

 
26,977

 
 
Less notes payable
 
 
2,170

 
4,244

 
 
Less current maturities
 
 
263,512

 
110,914

 
 
Total long-term debt
 
 
$
4,236,955

 
$
3,256,870

 
 

As of March 28, 2020 , the Company had $ 45,924 of borrowing availability under the $ 1,000,000 Revolving Loan Facility after taking into account $ 4,076 of standby and trade letters of credit issued and outstanding under this facility. In March 2020, in response to the uncertainty of the circumstances surrounding the COVID-19 global pandemic, the Company drew down $ 630,000 under the Revolving Loan Facility as a precautionary measure to provide the Company with additional financial flexibility to manage its business with a safety-first emphasis during the unknown duration and impact of the COVID-19 global pandemic. The Company subsequently repaid $ 490,000 of its borrowings under the Revolving Loan Facility in April 2020.
The Company entered into an accounts receivable securitization facility (the “Accounts Receivable Securitization Facility”) in November 2007. The Company’s maximum borrowing capacity under the Accounts Receivable Securitization Facility was $ 175,000 as of March 28, 2020 . Borrowings under the Accounts Receivable Securitization Facility are permitted only to the extent that the face of the receivables in the collateral pool, net of applicable reserves and other deductions, exceeds the outstanding loans and also subject to a fluctuating facility limit, not to exceed $ 225,000 . The Company had no borrowing availability under the Accounts Receivable Securitization Facility at March 28, 2020 .
The Company had $ 5,958 of borrowing availability under the Australian Revolving Loan Facility, no borrowing availability under the European Revolving Loan Facility and $ 134,716 of borrowing availability under other international credit facilities after taking into account outstanding borrowings and letters of credit outstanding under the applicable facilities at March 28, 2020 .
In March 2020, the Company amended the Accounts Receivable Securitization Facility. This amendment primarily decreased the fluctuating facility limit to $ 225,000 (previously $ 300,000 ) and extended the maturity date to March 2021 .
As of March 28, 2020 , the Company was in compliance with all financial covenants under its credit facilities and other outstanding indebtedness. The Company continues to monitor its covenant compliance carefully. Under the terms of its Senior Secured Credit Facility, among other financial and non-financial covenants, the Company is required to maintain a minimum interest coverage ratio and a maximum leverage ratio. The interest coverage ratio covenant is the ratio of the Company’s EBITDA for the preceding four fiscal quarters to its consolidated total interest expense and the maximum leverage ratio covenant is the ratio of the Company’s total debt to EBITDA for the preceding four fiscal quarters. EBITDA is defined as earnings before interest, income taxes, depreciation expense and amortization, as computed pursuant to the Senior Secured Credit Facility.

12

HANESBRANDS INC.
Notes to Condensed Consolidated Financial Statements — (Continued)
(amounts in thousands, except per share data)
(unaudited)

In April 2020, given the rapidly changing environment and level of uncertainty being created by the COVID-19 global pandemic and the associated impact on future earnings, the Company amended its Senior Secured Credit Facility prior to any potential covenant violation in order to modify the financial covenants and to provide operating flexibility during the COVID-19 crisis. The amendment effects changes to certain provisions and covenants under the Senior Secured Credit Facility during the period beginning with the fiscal quarter ending June 27, 2020 and continuing through the fiscal quarter ending July 3, 2021 (such period of time, the “Covenant Relief Period”), including: (a) suspension of compliance with the maximum leverage ratio; (b) reduction of the minimum interest coverage ratio from 3.00 to 1.00 to (i) 2.00 to 1.00 for the fiscal quarters ending June 27, 2020 through April 3, 2021 and (ii) 2.25 to 1.00 for the fiscal quarter ending July 3, 2021; (c) a minimum last twelve months EBITDA covenant of $ 625,000 as of June 27, 2020, $ 505,000 as of September 26, 2020, $ 445,000 as of January 2, 2021, $ 435,000 as of April 3, 2021 and $ 505,000 as of July 3, 2021; (d) a minimum liquidity covenant of $ 300,000 , increasing to $ 400,000 upon certain conditions; (e) increased limitations on investments, acquisitions, restricted payments and the incurrence of indebtedness; and (f) anti-cash hoarding provisions. During the Covenant Relief Period, the applicable margin and applicable commitment fee margin will be calculated assuming the leverage ratio is greater than or equal to 4.50 to 1.00. The amendment also permanently amends the definition of “leverage ratio” for purposes of the financial covenant calculation to remove the maximum amount of cash allowed to be netted from the definition of “indebtedness” and to allow for the netting of cash from certain foreign subsidiaries. After obtaining the debt amendment, the Company expects to maintain compliance with its covenants for at least one year from the issuance of these financial statements based on its current expectations and forecasts. If economic conditions caused by the COVID-19 global pandemic worsen and the Company’s earnings and operating cash flows do not start to recover as currently estimated by management, this could impact the Company’s ability to maintain compliance with its amended financial covenants and require the Company to seek additional amendments to its Senior Secured Credit Facility. If the Company is not able to obtain such necessary additional amendments, this would lead to an event of default and, if not cured timely, its lenders could require the Company to repay its outstanding debt. In that situation, the Company may not be able to raise sufficient debt or equity capital, or divest assets, to refinance or repay the lenders.
(8)
Accumulated Other Comprehensive Loss
The components of accumulated other comprehensive loss (“AOCI”) are as follows:
 
Cumulative Translation Adjustment (1)
 
Cash Flow Hedges
 
Defined Benefit Plans
 
Income Taxes
 
Accumulated Other Comprehensive Loss
Balance at December 28, 2019
$
( 157,138
)
 
$
4,786

 
$
( 629,360
)
 
$
164,064

 
$
( 617,648
)
Amounts reclassified from accumulated other comprehensive loss

 
( 5,017
)
 
4,866

 

 
( 151
)
Current-period other comprehensive income (loss) activity
( 117,154
)
 
20,080

 

 
( 8,552
)
 
( 105,626
)
 
 
 
 
 
 
 
 
 
 
Balance at March 28, 2020
$
( 274,292
)
 
$
19,849

 
$
( 624,494
)
 
$
155,512

 
$
( 723,425
)

 
 
(1)
Cumulative Translation Adjustment includes translation adjustments and net investment hedges. See Note, “Financial Instruments and Risk Management” for additional disclosures about net investment hedges.

13

HANESBRANDS INC.
Notes to Condensed Consolidated Financial Statements — (Continued)
(amounts in thousands, except per share data)
(unaudited)

The Company had the following reclassifications out of AOCI:
Component of AOCI
 
Location of Reclassification into Income
 
Amount of Reclassification from AOCI
 
Quarters Ended
 
March 28,
2020
 
March 30,
2019
Gain on foreign exchange contracts designated as cash flow hedges
 
Cost of sales
 
$
5,017

 
$
6,017


 
Income tax
 
( 1,272
)
 
( 1,521
)

 
Net of tax
 
3,745

 
4,496

 
 
 
 
 
 
 
Amortization of deferred actuarial loss and prior service cost
 
Other expenses
 
( 4,866
)
 
( 4,602
)

 
Income tax
 
1,272

 
1,205


 
Net of tax
 
( 3,594
)
 
( 3,397
)
 
 
 
 
 
 
 
Total reclassifications
 
 
 
$
151

 
$
1,099


(9)
Financial Instruments and Risk Management
The Company uses forward foreign exchange contracts to manage its exposures to movements in foreign exchange rates. The Company also uses a combination of derivative instruments and long-term debt to manage its exposure to foreign currency risk associated with the Company’s net investment in its European subsidiaries.
As of March 28, 2020 , the notional U.S. dollar equivalent of the Company’s derivative portfolio of forward foreign exchange contracts was $ 553,575 , consisting of contracts hedging exposures primarily related to the Euro, Australian dollar, Canadian dollar and Mexican peso. As of March 28, 2020 , the U.S. dollar equivalent carrying value of long-term debt designated as a partial European net investment hedge was $ 556,793 . The notional U.S. dollar equivalent of the Company’s cross-currency swap contracts, which are also designated as partial European net investment hedges, was $ 335,940 as of March 28, 2020 .
Fair Values of Derivative Instruments
The fair values of derivative financial instruments related to forward foreign exchange contracts and cross-currency swap contracts recognized in the Condensed Consolidated Balance Sheets of the Company were as follows:
 
Balance Sheet Location
 
Fair Value
 
March 28,
2020
 
December 28,
2019
Derivatives designated as hedging instruments:
 
 
 
 
 
Forward foreign exchange contracts
Other current assets
 
$
17,312

 
$
2,716

Cross-currency swap contracts
Other current assets
 
2,873

 
926

Cross-currency swap contracts
Other noncurrent assets
 
18,868

 
2,975

Derivatives not designated as hedging instruments:
 
 
 
 
 
Forward foreign exchange contracts
Other current assets
 
15,747

 
5,314

Total derivative assets
 
 
54,800

 
11,931

 
 
 
 
 
 
Derivatives designated as hedging instruments:
 
 
 
 
 
Forward foreign exchange contracts
Accrued liabilities
 
( 6
)
 
( 2,246
)
Derivatives not designated as hedging instruments:
 
 
 
 
 
Forward foreign exchange contracts
Accrued liabilities
 
( 3,263
)
 
( 1,147
)
Total derivative liabilities
 
 
( 3,269
)
 
( 3,393
)
 
 
 
 
 
 
Net derivative asset
 
 
$
51,531

 
$
8,538



14

HANESBRANDS INC.
Notes to Condensed Consolidated Financial Statements — (Continued)
(amounts in thousands, except per share data)
(unaudited)

Cash Flow Hedges
The Company uses forward foreign exchange contracts to reduce the effect of fluctuating foreign currencies on short-term foreign currency-denominated transactions, foreign currency-denominated investments and other known foreign currency exposures. Gains and losses on these contracts are intended to offset losses and gains on the hedged transaction in an effort to reduce the earnings volatility resulting from fluctuating foreign currency exchange rates.
The Company expects to reclassify into earnings during the next 12 months a net gain from AOCI of approximately $ 21,396 . The Company is hedging exposure to the variability in future cash flows for forecasted transactions over the next 14 months.
The effect of cash flow hedge derivative instruments on the Condensed Consolidated Statements of Income and AOCI is as follows:
 
Amount of Gain Recognized in AOCI on Derivative Instruments
 
Quarters Ended
 
March 28,
2020
 
March 30,
2019
Foreign exchange contracts
$
20,080

 
$
440

 
Location of Gain
Reclassified from AOCI 
into Income
 
Amount of Gain Reclassified from AOCI into Income
 
 
Quarters Ended
 
 
March 28,
2020
 
March 30,
2019
Foreign exchange contracts (1)
Cost of sales
 
$
5,017

 
$
6,017


 
 
(1)
The Company does not exclude amounts from effectiveness testing for cash flow hedges that would require recognition into earnings based on changes in fair value.
   
Quarters Ended
   
March 28,
2020
 
March 30,
2019
Total cost of sales in which the effects of cash flow hedges are recorded
$
842,730

 
$
967,993


Net Investment Hedges
In July 2019, the Company entered into two pay-fixed rate, receive-fixed rate cross-currency swap contracts with a total notional amount of 300,000 that were designated as hedges of a portion of the beginning balance of the Company’s net investment in its European subsidiaries. These cross-currency swap contracts, which mature on May 15, 2024, swap U.S. dollar-denominated interest payments for Euro-denominated interest payments, thereby economically converting a portion of the Company’s fixed-rate 4.625 % Senior Notes to a fixed-rate 2.3215 % Euro-denominated obligation.
In July 2019, the Company also designated its 3.5 % Senior Notes with a carrying value of 500,000 , which is a nonderivative financial instrument, as a hedge of a portion of the beginning balance of the Company’s European net investment.

15

HANESBRANDS INC.
Notes to Condensed Consolidated Financial Statements — (Continued)
(amounts in thousands, except per share data)
(unaudited)

The amount of after-tax gains included in AOCI in the Condensed Consolidated Balance Sheets related to derivative instruments and nonderivative financial instruments designated as net investment hedges and the amount of gains included in the “Interest expense, net” line in the Condensed Consolidated Statements of Income related to amounts excluded from the assessment of hedge effectiveness for derivative instruments designated as net investment hedges are as follows:
 
 
 
Amount of Gain Recognized in AOCI
 
 
 
Quarters Ended
 
 
 
March 28,
2020
 
March 30,
2019
Euro-denominated long-term debt
 
$
2,658

 
$

Cross-currency swap contracts
 
11,732

 

Total
 
$
14,390

 
$

 
Location of Gain Recognized in Income
 
Amount of Gain Recognized in Income
(Amount Excluded from Effectiveness Testing)
 
 
Quarters Ended
 
 
March 28,
2020
 
March 30,
2019
Cross-currency swap contracts
Interest expense, net
 
$
1,947

 
$

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Quarters Ended
 
 
 
March 28,
2020
 
March 30,
2019
Total interest expense, net in which the amounts excluded from effectiveness testing for net investment hedges are recorded
 
$
36,849

 
$
48,059


Mark to Market Hedges
A derivative used as a hedging instrument whose change in fair value is recognized to act as a hedge against changes in the values of the hedged item is designated as a mark to market hedge. The Company uses foreign exchange derivative contracts as hedges against the impact of foreign exchange fluctuations on existing accounts receivable and payable balances and intercompany lending transactions denominated in foreign currencies. Foreign exchange derivative contracts are recorded as mark to market hedges when the hedged item is a recorded asset or liability that is revalued in each accounting period. These contracts are not designated as hedges under the accounting standards and are recorded at fair value in the Condensed Consolidated Balance Sheets. Any gains or losses resulting from changes in fair value are recognized directly into earnings. Gains or losses on these contracts largely offset the net remeasurement gains or losses on the related assets and liabilities.
The effect of derivative contracts not designated as hedges on the Condensed Consolidated Statements of Income is as follows:
 
Location of Gain (Loss)
Recognized in Income
on Derivatives
 
Amount of Gain (Loss) Recognized in Income
 
Quarters Ended
 
March 28,
2020
 
March 30,
2019
Foreign exchange contracts
Cost of sales
 
$
6,121

 
$
( 9,397
)
Foreign exchange contracts
Selling, general and administrative expenses
 
( 1,031
)
 
( 659
)
Total
 
 
$
5,090

 
$
( 10,056
)


16

HANESBRANDS INC.
Notes to Condensed Consolidated Financial Statements — (Continued)
(amounts in thousands, except per share data)
(unaudited)

(10)
Fair Value of Assets and Liabilities
As of March 28, 2020 , the Company held certain financial assets and liabilities that are required to be measured at fair value on a recurring basis. These consisted of the Company’s derivative instruments related to forward foreign exchange derivative contracts, cross-currency swap derivative contracts and deferred compensation plan liabilities. The fair values of forward foreign exchange derivative contracts are determined using the cash flows of the forward contracts, discount rates to account for the passage of time and current foreign exchange market data which are all based on inputs readily available in public markets and are categorized as Level 2. The fair values of cross-currency swap derivative contracts are determined using the cash flows of the swap contracts, discount rates to account for the passage of time, current foreign exchange and interest rate market data and credit risk, which are all based on inputs readily available in public markets and are categorized as Level 2. The fair value of deferred compensation plans is based on readily available current market data and is categorized as Level 2. The Company’s defined benefit pension plan investments are not required to be measured at fair value on a quarterly recurring basis.
There were no changes during the quarter ended March 28, 2020 to the Company’s valuation techniques used to measure asset and liability fair values on a recurring basis. As of and during the quarter ended March 28, 2020 , the Company did not have any non-financial assets or liabilities that were required to be measured at fair value on a recurring or non-recurring basis.
The following tables set forth by level within the fair value hierarchy the Company’s financial assets and liabilities accounted for at fair value on a recurring basis.
 
Assets (Liabilities) at Fair Value as of
March 28, 2020
 
Total
 
Quoted Prices In
Active Markets
for Identical
Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Forward foreign exchange contracts - assets
$
33,059

 
$

 
$
33,059

 
$

Cross-currency swap contracts - assets
21,741

 

 
21,741

 

Forward foreign exchange contracts - liabilities
( 3,269
)
 

 
( 3,269
)
 

 
51,531

 

 
51,531

 

Deferred compensation plan liability
( 17,490
)
 

 
( 17,490
)
 

Total
$
34,041

 
$

 
$
34,041

 
$

 
 
Assets (Liabilities) at Fair Value as of
December 28, 2019
 
Total
 
Quoted Prices In
Active Markets
for Identical
Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Forward foreign exchange contracts - assets
$
8,030

 
$

 
$
8,030

 
$

Cross-currency swap contracts - assets
3,901

 

 
3,901

 

Forward foreign exchange contracts - liabilities
( 3,393
)
 

 
( 3,393
)
 

 
8,538

 

 
8,538

 

Deferred compensation plan liability
( 31,221
)
 

 
( 31,221
)
 

Total
$
( 22,683
)
 
$

 
$
( 22,683
)
 
$



17

HANESBRANDS INC.
Notes to Condensed Consolidated Financial Statements — (Continued)
(amounts in thousands, except per share data)
(unaudited)

Fair Value of Financial Instruments
The carrying amounts of cash and cash equivalents, trade accounts receivable, notes receivable and accounts payable approximated fair value as of March 28, 2020 and December 28, 2019 . The carrying amount of trade accounts receivable included allowance for doubtful accounts, chargebacks and other deductions of $ 46,079 and $ 33,228 as of March 28, 2020 and December 28, 2019 , respectively. The fair value of debt, which is classified as a Level 2 liability, was $ 4,408,038 and $ 3,560,623 as of March 28, 2020 and December 28, 2019 , respectively. Debt had a carrying value of $ 4,526,122 and $ 3,394,761 as of March 28, 2020 and December 28, 2019 , respectively. The fair values were estimated using quoted market prices as provided in secondary markets, which consider the Company’s credit risk and market related conditions. The carrying amount of the Company’s notes payable, which is classified as a Level 2 liability, approximated fair value as of March 28, 2020 and December 28, 2019 , primarily due to the short-term nature of these instruments.
(11)
Income Taxes
The Company’s effective income tax rate was 14.5 % and 13.9 % for the quarters ended March 28, 2020 and March 30, 2019 , respectively. The effective tax rate was lower for the quarter ended March 30, 2019 due to the inclusion of a net discrete benefit of $ 3,026 .
During the quarter ended March 28, 2020 , the Internal Revenue Service closed the examination of the income tax years ended January 2, 2016 and December 31, 2016. The examination resulted in an immaterial adjustment which had been accrued as an uncertain tax benefit in a prior period. The Company remains subject to examinations in other jurisdictions and believes that it maintains appropriate uncertain tax benefit reserves, which are re-evaluated each quarter. Management believes it is reasonably possible that the amount of uncertain tax benefits may decrease by approximately $ 25,318 in the next twelve months based on approvals of certain filings by tax authorities with approximately $ 15,261 of the reduction impacting the effective tax rate.
As a result of the COVID-19 pandemic, governments are offering various relief mechanisms to taxpayers to assist with the business disruption. The measures vary by jurisdiction, but often include the ability to delay certain income tax payments. The Company intends to use these provisions where eligible. As of March 28, 2020 , the COVID-19 relief measures do not have a material impact on the effective tax rate or other income tax accounts, including income taxes payable.
(12)
Business Segment Information
The Company’s operations are managed and reported in three operating segments, each of which is a reportable segment for financial reporting purposes: Innerwear, Activewear and International. These segments are organized principally by product category and geographic location. Each segment has its own management team that is responsible for the operations of the segment’s businesses, but the segments share a common supply chain and media and marketing platforms. Other consists of the Company’s U.S. value-based (“outlet”) stores and U.S. hosiery business.
The types of products and services from which each reportable segment derives its revenues are as follows:
Innerwear includes sales of basic branded apparel products that are replenishment in nature under the product categories of men’s underwear, women’s panties, children’s underwear and socks, and intimate apparel, which includes bras and shapewear.
Activewear includes sales of basic branded products that are primarily seasonal in nature to both retailers and wholesalers, as well as licensed sports apparel and licensed logo apparel in collegiate bookstores, mass retailers and other channels.
International includes sales of products in all of the Company’s categories outside the United States, primarily in Europe, Australia, Asia, Latin America and Canada.  

18

HANESBRANDS INC.
Notes to Condensed Consolidated Financial Statements — (Continued)
(amounts in thousands, except per share data)
(unaudited)

The Company evaluates the operating performance of its segments based upon segment operating profit, which is defined as operating profit before general corporate expenses, restructuring and other action-related charges and amortization of intangibles. The accounting policies of the segments are consistent with those described in Note, “Summary of Significant Accounting Policies” to the Company’s consolidated financial statements included in its Annual Report on Form 10-K for the year ended December 28, 2019 .
 
Quarters Ended
March 28,
2020
 
March 30,
2019
Net sales:
 
 
 
Innerwear
$
422,402

 
$
475,945

Activewear
288,000

 
405,340

International
555,901

 
646,180

Other
50,159

 
60,559

Total net sales
$
1,316,462

 
$
1,588,024


 
Quarters Ended
 
March 28,
2020
 
March 30,
2019
Segment operating profit:
 
 
 
Innerwear
$
81,551

 
$
104,626

Activewear
8,108

 
43,593

International
52,018

 
99,773

Other
( 6,125
)
 
754

Total segment operating profit
135,552

 
248,746

Items not included in segment operating profit:
 
 
 
General corporate expenses
( 63,633
)
 
( 68,349
)
Restructuring and other action-related charges
( 29,199
)
 
( 21,373
)
Amortization of intangibles
( 8,590
)
 
( 9,380
)
Total operating profit
34,130

 
149,644

Other expenses
( 6,490
)
 
( 7,451
)
Interest expense, net
( 36,849
)
 
( 48,059
)
Income (loss) before income tax expense
$
( 9,209
)
 
$
94,134


For the quarter ended March 28, 2020 , the Company incurred pre-tax restructuring and other action-related charges of $ 29,199 , of which $ 21,813 is reported in the “Cost of sales” line and $ 7,386 is reported in the “Selling, general and administrative expenses” line in the Condensed Consolidated Statement of Income. For the quarter ended March 30, 2019 , the Company incurred pre-tax restructuring and other action-related charges of $ 21,373 , of which $ 17,692 is reported in the “Cost of sales” line and $ 3,681 is reported in the “Selling, general and administrative expenses” line in the Condensed Consolidated Statement of Income.
As of December 28, 2019 , the Company had an accrual of $ 7,120 for expected benefit payments related to actions taken in prior years. During the quarter ended March 28, 2020 , the Company approved actions related to corporate workforce reductions and incurred charges of $ 5,258 for employee termination and other benefits for employees affected by separation programs all of which are reflected in the “Selling, general and administrative expenses” line in the Condensed Consolidated Statement of Income. During quarter ended March 28, 2020 , benefit payments, other accrual adjustments and foreign currency adjustments of $ 2,616 have been made, resulting in an ending accrual of $ 9,762 , of which $ 8,741 and $ 1,021 is included in the “Accrued liabilities” and “Other noncurrent liabilities” lines of the Condensed Consolidated Balance Sheet, respectively.

19

HANESBRANDS INC.
Notes to Condensed Consolidated Financial Statements — (Continued)
(amounts in thousands, except per share data)
(unaudited)

(13)
Revisions of Previously Issued Condensed Consolidated Interim Financial Statements
As described in Note, "Basis of Presentation," the following tables set forth the impact of error corrections on the Company’s condensed consolidated interim financial statements as of and for the periods ended March 30, 2019 , June 29, 2019 and September 28, 2019 by financial statement line item.
 
Quarter Ended March 30, 2019
Condensed Consolidated Statement of Income Line Item
As Previously Reported
 
Adjustments
 
As Revised
Cost of sales
$
967,148

 
$
845

 
$
967,993

Gross profit
620,876

 
( 845
)
 
620,031

Selling, general and administrative expenses
472,838

 
( 2,451
)
 
470,387

Operating profit
148,038

 
1,606

 
149,644

Income before income tax expense
92,528

 
1,606

 
94,134

Net income
79,482

 
1,606

 
81,088

 
 
 
 
 
 
Earnings per share:
 
 
 
 
 
Basic
$
0.22

 
$
0.00

 
$
0.22

Diluted
$
0.22

 
$
0.00

 
$
0.22


 
Quarter Ended March 30, 2019
Condensed Consolidated Statement of Comprehensive Income Line Item
As Previously Reported
 
Adjustments
 
As Revised
Net income
$
79,482

 
$
1,606

 
$
81,088

Translation adjustments
14,461

 
( 7,075
)
 
7,386

Total other comprehensive income
13,939

 
( 7,075
)
 
6,864

Comprehensive income
93,421

 
( 5,469
)
 
87,952


 
March 30, 2019
Condensed Consolidated Balance Sheet Line Item
As Previously Reported
 
Adjustments
 
As Revised
Inventories
$
2,235,809

 
$
( 3,090
)
 
$
2,232,719

Other current assets
166,123

 
22,889

 
189,012

Total current assets
3,621,887

 
19,799

 
3,641,686

Deferred tax assets
257,393

 
( 43,665
)
 
213,728

Total assets
7,848,025

 
( 23,866
)
 
7,824,159

Accrued liabilities
552,012

 
16,438

 
568,450

Total current liabilities
2,182,435

 
16,438

 
2,198,873

Other noncurrent liabilities
286,625

 
64,743

 
351,368

Total liabilities
6,809,987

 
81,181

 
6,891,168

Retained earnings
1,296,158

 
( 105,047
)
 
1,191,111

Total stockholders’ equity
1,038,038

 
( 105,047
)
 
932,991

Total liabilities and stockholders’ equity
7,848,025

 
( 23,866
)
 
7,824,159


 
Quarter Ended March 30, 2019
Condensed Consolidated Statement of Stockholders’ Equity Line Item
As Previously Reported
 
Adjustments
 
As Revised
Balance at December 29, 2018
$
970,283

 
$
( 98,157
)
 
$
872,126

Net income
79,482

 
1,606

 
81,088

Other comprehensive income
13,939

 
( 7,075
)
 
6,864

Cumulative effect of change in adoption of leases standard
7,977

 
( 1,421
)
 
6,556

Balance at March 30, 2019
1,038,038

 
( 105,047
)
 
932,991



20

HANESBRANDS INC.
Notes to Condensed Consolidated Financial Statements — (Continued)
(amounts in thousands, except per share data)
(unaudited)

 
Quarter Ended March 30, 2019
Condensed Consolidated Statement of Cash Flows Line Item
As Previously Reported
 
Adjustments
 
As Revised
Operating activities:
 
 
 
 
 
Net income
$
79,482

 
$
1,606

 
$
81,088

Adjustments to reconcile net income to net cash from operating activities:
 
 
 
 
 
Other
11,322

 
( 7,075
)
 
4,247

Changes in assets and liabilities:
 
 
 
 
 
Inventories
( 183,875
)
 
5,470

 
( 178,405
)
Other assets
( 31,629
)
 
( 743
)
 
( 32,372
)
Accrued liabilities and other
( 3,120
)
 
742

 
( 2,378
)
Net cash from operating activities
( 194,291
)
 

 
( 194,291
)

 
Quarter Ended June 29, 2019
Condensed Consolidated Statement of Income Line Item
As Previously Reported
 
Adjustments
 
As Revised
Cost of sales
$
1,086,248

 
$
( 844
)
 
$
1,085,404

Gross profit
674,679

 
844

 
675,523

Selling, general and administrative expenses
440,662

 
5,261

 
445,923

Operating profit
234,017

 
( 4,417
)
 
229,600

Income before income tax expense
179,246

 
( 4,417
)
 
174,829

Net income
153,972

 
( 4,417
)
 
149,555

 
 
 
 
 
 
Earnings per share:
 
 
 
 
 
Basic
$
0.42

 
$
( 0.01
)
 
$
0.41

Diluted
$
0.42

 
$
( 0.01
)
 
$
0.41


 
Six Months Ended June 29, 2019
Condensed Consolidated Statement of Income Line Item
As Previously Reported
 
Adjustments
 
As Revised
Cost of sales
$
2,053,396

 
$
1

 
$
2,053,397

Gross profit
1,295,555

 
( 1
)
 
1,295,554

Selling, general and administrative expenses
913,500

 
2,810

 
916,310

Operating profit
382,055

 
( 2,811
)
 
379,244

Income before income tax expense
271,774

 
( 2,811
)
 
268,963

Net income
233,454

 
( 2,811
)
 
230,643

 
 
 
 
 
 
Earnings per share:
 
 
 
 
 
Basic
$
0.64

 
$
( 0.01
)
 
$
0.63

Diluted
$
0.64

 
$
( 0.01
)
 
$
0.63


 
Quarter Ended June 29, 2019
Condensed Consolidated Statement of Comprehensive Income Line Item
As Previously Reported
 
Adjustments
 
As Revised
Net income
$
153,972

 
$
( 4,417
)
 
$
149,555

Comprehensive income
149,165

 
( 4,417
)
 
144,748



21

HANESBRANDS INC.
Notes to Condensed Consolidated Financial Statements — (Continued)
(amounts in thousands, except per share data)
(unaudited)

 
Six Months Ended June 29, 2019
Condensed Consolidated Statement of Comprehensive Income Line Item
As Previously Reported
 
Adjustments
 
As Revised
Net income
$
233,454

 
$
( 2,811
)
 
$
230,643

Translation adjustments
11,259

 
( 7,075
)
 
4,184

Total other comprehensive income
9,132

 
( 7,075
)
 
2,057

Comprehensive income
242,586

 
( 9,886
)
 
232,700


 
June 29, 2019
Condensed Consolidated Balance Sheet Line Item
As Previously Reported
 
Adjustments
 
As Revised
Inventories
$
2,233,760

 
$
( 10,561
)
 
$
2,223,199

Other current assets
152,925

 
23,371

 
176,296

Total current assets
3,656,442

 
12,810

 
3,669,252

Deferred tax assets
264,592

 
( 43,665
)
 
220,927

Total assets
7,876,892

 
( 30,855
)
 
7,846,037

Accrued liabilities
547,306

 
13,866

 
561,172

Total current liabilities
2,069,817

 
13,866

 
2,083,683

Other noncurrent liabilities
277,742

 
64,743

 
342,485

Total liabilities
6,742,042

 
78,609

 
6,820,651

Retained earnings
1,395,306

 
( 109,464
)
 
1,285,842

Total stockholders’ equity
1,134,850

 
( 109,464
)
 
1,025,386

Total liabilities and stockholders’ equity
7,876,892

 
( 30,855
)
 
7,846,037


 
Quarter Ended June 29, 2019
Condensed Consolidated Statement of Stockholders’ Equity Line Item
As Previously Reported
 
Adjustments
 
As Revised
Balance at March 30, 2019
$
1,038,038

 
$
( 105,047
)
 
$
932,991

Net income
153,972

 
( 4,417
)
 
149,555

Balance at June 29, 2019
1,134,850

 
( 109,464
)
 
1,025,386


 
Six Months Ended June 29, 2019
Condensed Consolidated Statement of Stockholders’ Equity Line Item
As Previously Reported
 
Adjustments
 
As Revised
Balance at December 29, 2018
$
970,283

 
$
( 98,157
)
 
$
872,126

Net income
233,454

 
( 2,811
)
 
230,643

Other comprehensive income
9,132

 
( 7,075
)
 
2,057

Cumulative effect of change in adoption of leases standard
7,977

 
( 1,421
)
 
6,556

Balance at June 29, 2019
1,134,850

 
( 109,464
)
 
1,025,386


 
Six Months Ended June 29, 2019
Condensed Consolidated Statement of Cash Flows Line Item
As Previously Reported
 
Adjustments
 
As Revised
Operating activities:
 
 
 
 
 
Net income
$
233,454

 
$
( 2,811
)
 
$
230,643

Adjustments to reconcile net income to net cash from operating activities:
 
 
 
 
 
Other
12,550

 
( 7,075
)
 
5,475

Changes in assets and liabilities:
 
 
 
 
 
Inventories
( 178,453
)
 
12,941

 
( 165,512
)
Other assets
( 27,354
)
 
( 1,225
)
 
( 28,579
)
Accrued liabilities and other
( 23,405
)
 
( 1,830
)
 
( 25,235
)
Net cash from operating activities
( 57,363
)
 

 
( 57,363
)

22

HANESBRANDS INC.
Notes to Condensed Consolidated Financial Statements — (Continued)
(amounts in thousands, except per share data)
(unaudited)


 
Quarter Ended September 28, 2019
Condensed Consolidated Statement of Income Line Item
As Previously Reported
 
Adjustments
 
As Revised
Cost of sales
1,154,629

 
( 4,695
)
 
$
1,149,934

Gross profit
712,338

 
4,695

 
717,033

Selling, general and administrative expenses
442,582

 
7,380

 
449,962

Operating profit
269,756

 
( 2,685
)
 
267,071

Income before income tax expense
218,599

 
( 2,685
)
 
215,914

Net income
187,776

 
( 2,685
)
 
185,091

 
 
 
 
 
 
Earnings per share:
 
 
 
 
 
Basic
$
0.51

 
$
( 0.01
)
 
$
0.51

Diluted
$
0.51

 
$
( 0.01
)
 
$
0.51


 
Nine Months Ended September 28, 2019
Condensed Consolidated Statement of Income Line Item
As Previously Reported
 
Adjustments
 
As Revised
Cost of sales
$
3,208,025

 
$
( 4,694
)
 
$
3,203,331

Gross profit
2,007,893

 
4,694

 
2,012,587

Selling, general and administrative expenses
1,356,082

 
10,190

 
1,366,272

Operating profit
651,811

 
( 5,496
)
 
646,315

Income before income tax expense
490,373

 
( 5,496
)
 
484,877

Net income
421,230

 
( 5,496
)
 
415,734

 
 
 
 
 
 
Earnings per share:
 
 
 
 
 
Basic
$
1.16

 
$
( 0.02
)
 
$
1.14

Diluted
$
1.15

 
$
( 0.02
)
 
$
1.14


 
Quarter Ended September 28, 2019
Condensed Consolidated Statement of Comprehensive Income Line Item
As Previously Reported
 
Adjustments
 
As Revised
Net income
$
187,776

 
$
( 2,685
)
 
$
185,091

Comprehensive income
148,443

 
( 2,685
)
 
145,758


 
Nine Months Ended September 28, 2019
Condensed Consolidated Statement of Comprehensive Income Line Item
As Previously Reported
 
Adjustments
 
As Revised
Net income
$
421,230

 
$
( 5,496
)
 
$
415,734

Translation adjustments
( 33,738
)
 
( 7,075
)
 
( 40,813
)
Total other comprehensive loss
( 30,201
)
 
( 7,075
)
 
( 37,276
)
Comprehensive income
391,029

 
( 12,571
)
 
378,458



23

HANESBRANDS INC.
Notes to Condensed Consolidated Financial Statements — (Continued)
(amounts in thousands, except per share data)
(unaudited)

 
September 28, 2019
Condensed Consolidated Balance Sheet Line Item
As Previously Reported
 
Adjustments
 
As Revised
Inventories
$
2,108,281

 
$
( 13,246
)
 
$
2,095,035

Other current assets
166,727

 
7,445

 
174,172

Total current assets
3,625,970

 
( 5,801
)
 
3,620,169

Deferred tax assets
257,314

 
( 43,665
)
 
213,649

Total assets
7,773,298

 
( 49,466
)
 
7,723,832

Accrued liabilities
589,992

 
( 2,060
)
 
587,932

Total current liabilities
2,096,904

 
( 2,060
)
 
2,094,844

Other noncurrent liabilities
265,804

 
64,743

 
330,547

Total liabilities
6,543,056

 
62,683

 
6,605,739

Retained earnings
1,528,258

 
( 112,149
)
 
1,416,109

Total stockholders’ equity
1,230,242

 
( 112,149
)
 
1,118,093

Total liabilities and stockholders’ equity
7,773,298

 
( 49,466
)
 
7,723,832


 
Quarter Ended September 28, 2019
Condensed Consolidated Statement of Stockholders’ Equity Line Item
As Previously Reported
 
Adjustments
 
As Revised
Balance at June 29, 2019
$
1,134,850

 
$
( 109,464
)
 
$
1,025,386

Net income
187,776

 
( 2,685
)
 
185,091

Balance at September 28, 2019
1,230,242

 
( 112,149
)
 
1,118,093


 
Nine Months Ended September 28, 2019
Condensed Consolidated Statement of Stockholders’ Equity Line Item
As Previously Reported
 
Adjustments
 
As Revised
Balance at December 29, 2018
$
970,283

 
$
( 98,157
)
 
$
872,126

Net income
421,230

 
( 5,496
)
 
415,734

Other comprehensive income
( 30,201
)
 
( 7,075
)
 
( 37,276
)
Cumulative effect of change in adoption of leases standard
7,977

 
( 1,421
)
 
6,556

Balance at September 28, 2019
1,230,242

 
( 112,149
)
 
1,118,093


 
Nine Months Ended September 28, 2019
Condensed Consolidated Statement of Cash Flows Line Item
As Previously Reported
 
Adjustments
 
As Revised
Operating activities:
 
 
 
 
 
Net income
$
421,230

 
$
( 5,496
)
 
$
415,734

Adjustments to reconcile net income to net cash from operating activities:
 
 
 
 
 
Other
8,737

 
( 7,075
)
 
1,662

Changes in assets and liabilities, net of acquisition of businesses:
 
 
 
 
 
Inventories
( 72,096
)
 
15,626

 
( 56,470
)
Other assets
( 40,732
)
 
14,701

 
( 26,031
)
Accrued liabilities and other
14,243

 
( 17,756
)
 
( 3,513
)
Net cash from operating activities
244,700

 

 
244,700



24


Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
This management’s discussion and analysis of financial condition and results of operations, or MD&A, contains forward-looking statements that involve risks and uncertainties. Please see “Forward-Looking Statements” in this Quarterly Report on Form 10-Q for a discussion of the uncertainties, risks and assumptions associated with these statements. This discussion should be read in conjunction with our historical financial statements and related notes thereto and the other disclosures contained elsewhere in this Quarterly Report on Form 10-Q. The unaudited condensed consolidated financial statements and notes included herein should be read in conjunction with our audited consolidated financial statements and notes for the year ended December 28, 2019 , which were included in our Annual Report on Form 10-K filed with the SEC. The results of operations for the periods reflected herein are not necessarily indicative of results that may be expected for future periods, and our actual results may differ materially from those discussed in the forward-looking statements as a result of various factors, including but not limited to those included in the “Risk Factors” section and elsewhere in this Quarterly Report on Form 10-Q and those included in the “Risk Factors” section and elsewhere in our Annual Report on Form 10-K for the year ended December 28, 2019 . In particular, statements with respect to trends associated with our business, our future financial performance and the potential effects of the global COVID-19 pandemic included in this Quarterly Report on Form 10-Q specifically appearing under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” include forward-looking statements. The unaudited condensed consolidated interim financial statements for the quarter ended March 30, 2019 have been revised to correct prior period errors as discussed in Note, “Basis of Presentation” and Note, “Revisions of Previously Issued Condensed Consolidated Interim Financial Statements” to our unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q. Accordingly, this MD&A reflects the impact of those revisions.
Overview
Hanesbrands Inc. (collectively with its subsidiaries, “we,” “us,” “our,” or the “Company”) is a socially responsible leading marketer of everyday basic innerwear and activewear apparel in the Americas, Europe, Australia and Asia/Pacific under some of the world’s strongest apparel brands, including Hanes, Champion, Bonds, DIM, Maidenform, Bali, Playtex, Lovable, Bras N Things, Nur Die/Nur Der, Alternative, L’eggs, JMS/Just My Size, Wonderbra, Berlei and Gear for Sports. We design, manufacture, source and sell a broad range of basic apparel such as T-shirts, bras, panties, men’s underwear, children’s underwear, activewear, socks and hosiery. Our brands hold either the number one or number two market position by units sold in many of the product categories and geographies in which we compete.
Our operations are managed and reported in three operating segments, each of which is a reportable segment for financial reporting purposes: Innerwear, Activewear and International. These segments are organized principally by product category and geographic location. Each segment has its own management team that is responsible for the operations of the segment’s businesses, but the segments share a common supply chain and media and marketing platforms. Other consists of our U.S. value-based (“outlet”) stores and U.S. hosiery business.
Impact of COVID-19 on Our Business
On March 11, 2020, the World Health Organization declared the novel strain of coronavirus (COVID-19) a global pandemic and recommended containment and mitigation measures worldwide. The pandemic and these containment and mitigation measures have led to adverse impacts on the U.S. and global economies. The COVID-19 pandemic has impacted our business operations and results of operations for the first quarter of 2020 as described in more detail under “Condensed Consolidated Results of Operations - First Quarter Ended March 28, 2020 Compared with First Quarter Ended March 30, 2019” below, due to decreased customer traffic and retail store closures worldwide. The evolving COVID-19 pandemic could continue to have an adverse impact on our results of operations and liquidity; the operations of our suppliers, vendors and customers; and on our employees as a result of quarantines, facility closures, and travel and logistics restrictions. While the ultimate health and economic impact of the COVID-19 pandemic is highly uncertain, we expect that our business operations and results of operations, including our net sales, earnings and cash flows, will be materially impacted for at least the balance of 2020, as a result of:
temporary closure of our owned and operated retail stores;
decreased customer traffic in retail stores;
changes in consumer confidence and consumer spending habits, including spending for the merchandise that we sell and negative trends in consumer purchasing patterns due to changes in consumers’ disposable income, credit availability and debt levels;
decreased discretionary consumer-directed channel spending independent of store closures;

25


decreased wholesale channel sales and increased likelihood of wholesale customer financial distress, including requests for extended payment terms or potential payment defaults;
disruption to our global supply chain including the manufacturing, supply, distribution, transportation and delivery of our products;
decreased productivity due to travel bans, work-from-home policies or shelter-in-place orders; and
a slowdown in the U.S. and global economies, and an uncertain global economic outlook or a potential credit crisis.
The extent to which the COVID-19 pandemic impacts our business operations, financial results, and liquidity will depend on numerous evolving factors that we may not be able to accurately predict or assess, including the duration and scope of the pandemic; our response to and ability to mitigate the impact of the pandemic; the negative impact it has on global and regional economies and economic activity, including the duration and magnitude of its impact on unemployment rates and consumer discretionary spending; its short- and longer-term impact on the levels of consumer confidence; the ability of our suppliers, vendors and customers to successfully address the impacts of the pandemic; actions governments, businesses and individuals take in response to the pandemic; and how quickly economies recover after the COVID-19 pandemic subsides.
We expect the negative impact of the COVID-19 pandemic to lead to continued net sales decreases due to our retail store closures and reduced net sales and earnings for our wholesale customers, some of which may experience financial distress or declare bankruptcy. Reduced retail sales or additional customer store closures and customer bankruptcies could reduce or eliminate our anticipated income and cash flows, which would negatively affect our results of operations and liquidity. Even if customers do not declare bankruptcy, they may seek to extend payment terms or be unable or unwilling to pay us amounts that we are entitled to on a timely basis or at all, which would adversely affect our sales and liquidity. Also, we could be required to record increased excess and obsolete inventory reserves due to decreased net sales or noncash impairment charges related to our intangible assets or goodwill due to reduced cash flows. Additionally, our retail stores and many of our manufacturing facilities are closed. Accordingly, these operations are not generating sales sufficient to offset fixed operating expenses, which is adversely affecting our income and could in the future adversely affect the value of our owned and leased properties, potentially requiring us to recognize significant noncash impairment charges.
We have been taking steps to mitigate the potential risks to us posed by the spread and related circumstances and impacts of COVID-19. We are focused on addressing these recent challenges presented by the COVID-19 global pandemic by preserving our liquidity and managing our cash flow with preemptive actions designed to enhance our ability to meet our short-term liquidity needs. Such actions include, but are not limited to, focusing on channels that continue to generate sales, including mass retail and online; developing a product line of masks and other personal protective garments; operating our manufacturing and distribution facilities on a demand-adjusted basis; reducing our discretionary spending such as media and marketing expenses; focused working capital management; reducing capital expenditures; suspending our share buyback program until further notice; reducing payroll costs, through employee furloughs and pay cuts; drawing down on our Revolving Loan Facility and amending certain existing debt facilities. These efforts may not be enough to offset anticipated declines in net sales and we may not be able to access sufficient additional working capital to meet our liquidity needs. See “ The novel coronavirus disease (COVID-19) global pandemic has had and is expected to continue to have an adverse impact on our business.” in Part II, Item 1A. Risk Factors of this Quarterly Report on Form 10-Q.
Outlook for 2020
We issued first-quarter and full-year 2020 guidance on February 7, 2020, which excluded any impact from the spread of the COVID-19 global pandemic. Due to the uncertainty and rapidly changing environment relating to the pandemic, on March 25, 2020, we withdrew the guidance for the first quarter and full year and are not providing an updated outlook at this time.
Seasonality and Other Factors
Absent the effects of the COVID-19 global pandemic, our operating results are typically subject to some variability due to seasonality and other factors. For instance, we have historically generated higher sales during the back-to-school and holiday shopping seasons and during periods of cooler weather, which benefits certain product categories such as fleece. Sales levels in any period are also impacted by customer decisions to increase or decrease their inventory levels in response to anticipated consumer demand. Our customers may cancel orders, change delivery schedules or change the mix of products ordered with minimal notice to us. Media, advertising and promotion expenses may vary from period to period during a fiscal year depending on the timing of our advertising campaigns for retail selling seasons and product introductions. We expect the duration and scope of the COVID-19 global pandemic to alter these patterns during 2020.

26


Although the majority of our products are replenishment in nature and tend to be purchased by consumers on a planned, rather than on an impulse, basis, our sales are impacted by discretionary spending by consumers. Discretionary spending is affected by many factors that are outside our control, including, among others, general business conditions, interest rates, inflation, consumer debt levels, the availability of consumer credit, currency exchange rates, taxation, energy prices, unemployment trends and other matters that influence consumer confidence and spending. Consumers’ purchases of discretionary items, including our products, could decline during periods when disposable income is lower, when prices increase in response to rising costs, or in periods of actual or perceived unfavorable economic conditions. In addition, the COVID-19 global pandemic may result in decreased consumer confidence and lower consumer spending. As a result, consumers may choose to purchase fewer of our products, to purchase lower-priced products of our competitors in response to higher prices for our products, or may choose not to purchase our products at prices that reflect our price increases that become effective from time to time.
Changes in product sales mix can impact our gross profit as the percentage of our sales attributable to higher margin products, such as intimate apparel and men’s underwear, and lower margin products, such as seasonal and replenishable activewear, fluctuate from time to time. In addition, sales attributable to higher and lower margin products within the same product category fluctuate from time to time. Our customers may change the mix of products ordered with minimal notice to us, which makes trends in product sales mix difficult to predict. However, certain changes in product sales mix are seasonal in nature, as sales of socks, hosiery and fleece products generally have higher sales during the last two quarters (July to December) of each fiscal year as a result of cooler weather, back-to-school shopping and holidays, while other changes in product mix may be attributable to consumers’ preferences and discretionary spending.
Overview of the First Quarter Ended March 28, 2020
The COVID-19 global pandemic adversely impacted our business operations and results of operations for the first quarter of 2020. Prior to the pandemic’s late-first quarter disruption of economies around the world, we experienced strong net sales and profit trends. As the COVID-19 virus spread around the world in March, net sales and profits across all our segments decreased dramatically.
Key financial results are as follows:
Total net sales in the first quarter of 2020 were $1.3 billion , compared with $1.6 billion in the same period of 2019 , representing a 17% decrease.
Operating profit decreased 77% to $34 million in the first quarter of 2020 , compared with $150 million in the same period of 2019 . As a percentage of sales, operating profit was 2.6% in the first quarter of 2020 compared to 9.4% in the same period of 2019 . Included within operating profit were restructuring and other action-related charges of $29 million and $21 million for the quarters ended March 28, 2020 and March 30, 2019 , respectively.
We estimate the impact of the COVID-19 global pandemic reduced net sales by approximately $181 million, operating profit by approximately $86 million and diluted earnings per share by approximately $0.20.
Operating cash flows increased $111 million in the first quarter of 2020 compared to the first quarter of 2019.
As part of our cash deployment strategy, prior to the global expansion of COVID-19, we entered into transactions to repurchase approximately 14.5 million shares at a weighted average repurchase price of $ 13.83 per share. The shares were repurchased at a total cost of $ 200 million.
In March 2020, in response to the uncertainty of the circumstances surrounding the COVID-19 global pandemic and as a precautionary measure to further strengthen our cash position, we drew down $630 million under the Revolving Loan Facility to provide us with additional financial flexibility to manage our business with a safety-first emphasis during the unknown duration and impact of the COVID-19 global pandemic. We subsequently repaid $490 million of this borrowing in April 2020.

27


Condensed Consolidated Results of Operations — First Quarter Ended March 28, 2020 Compared with First Quarter Ended March 30, 2019
 
 
Quarters Ended
 
 
 
 
 
March 28,
2020
 
March 30,
2019
 
Higher
(Lower)
 
Percent
Change
 
(dollars in thousands)
Net sales
$
1,316,462

 
$
1,588,024

 
$
(271,562
)
 
(17.1
)%
Cost of sales
842,730

 
967,993

 
(125,263
)
 
(12.9
)
Gross profit
473,732

 
620,031

 
(146,299
)
 
(23.6
)
Selling, general and administrative expenses
439,602

 
470,387

 
(30,785
)
 
(6.5
)
Operating profit
34,130

 
149,644

 
(115,514
)
 
(77.2
)
Other expenses
6,490

 
7,451

 
(961
)
 
(12.9
)
Interest expense, net
36,849

 
48,059

 
(11,210
)
 
(23.3
)
Income (loss) before income tax expense
(9,209
)
 
94,134

 
(103,343
)
 
(109.8
)
Income tax expense (benefit)
(1,335
)
 
13,046

 
(14,381
)
 
(110.2
)
Net Income (loss)
$
(7,874
)
 
$
81,088

 
$
(88,962
)
 
(109.7
)%
Net Sales
Through mid-March, we saw strong net sales and profit performance across our businesses, particularly within the Innerwear and Activewear segments. Shipments slowed nearly to a halt worldwide in the final two weeks of March as we and our retail customers closed stores and customer orders were canceled in response to the global expansion of COVID-19 and net sales and profit trends across all segments decreased dramatically.
Net sales decreased 17% during the first quarter of 2020 primarily due to the following:
The disruption of our U.S. and International businesses related to the negative effects of the COVID-19 pandemic, including closures of retail stores owned and operated by us, as well as canceled orders from our wholesale brick- and-mortar customers, decreased sales an estimated $181 million;
The exit of our C9 Champion program at Target and the DKNY Intimates license in 2019 which, together, represented approximately $94 million of net sales in the first quarter of 2019; and
The unfavorable impact from foreign exchange rates in our International business of approximately $20 million.
Excluding the negative impact of the COVID-19 global pandemic, the exited programs and foreign exchange rates, total constant-currency net sales for the first quarter of 2020 would have increased 1.6%.
Operating Profit
Operating profit as a percentage of sales was 2.6% , representing a decrease from 9.4% in the prior year. Decreased operating profit was the result of lower sales volume, higher manufacturing variances as a result of decreases in manufacturing facility production levels in our global supply chain due to the business disruption caused by the COVID-19 global pandemic and higher bad debt expense, as well as the exit of our C9 Champion program at Target in 2019. These decreases were partially offset by lower variable selling, general and administrative expenses as a result of decreased sales volume. Included in operating profit in the first quarter of 2020 and 2019 were charges of $29 million and $21 million , respectively, related to restructuring and other action-related charges.
Other Highlights
Other Expenses – Other expenses decreased $1 million in the first quarter of 2020 compared to the first quarter of 2019 primarily due to lower pension expense and lower funding fees for sales of accounts receivable to financial institutions in 2020.
Interest Expense – Interest expense was lower by $11 million in the first quarter of 2020 compared to the first quarter of 2019 driven by the impact of the cross-currency swap contracts entered into in July 2019, lower outstanding debt balances during the quarter and a lower weighted average interest rate on our borrowings. Our weighted average interest rate on our outstanding debt was 3.85% for the first quarter of 2020 , compared to 4.17% for the first quarter of 2019 .

28


Income Tax Expense – Our effective income tax rate was 14.5% and 13.9% for the first quarters of 2020 and 2019 , respectively. The effective tax rate was lower for the quarter ended March 30, 2019 due to the inclusion of a net discrete benefit of $3 million. During the quarter ended March 28, 2020 , the Internal Revenue Service closed the examination of the income tax years ended January 2, 2016 and December 31, 2016. The examination resulted in an immaterial adjustment which had been accrued as an uncertain tax benefit in a prior period.
Operating Results by Business Segment — First Quarter Ended March 28, 2020 Compared with First Quarter Ended March 30, 2019
 
 
Net Sales
 
 
 
 
 
Quarters Ended
 
 
 
 
 
March 28,
2020
 
March 30,
2019
 
Higher
(Lower)
 
Percent
Change
 
(dollars in thousands)
Innerwear
$
422,402

 
$
475,945

 
$
(53,543
)
 
(11.2
)%
Activewear
288,000

 
405,340

 
(117,340
)
 
(28.9
)
International
555,901

 
646,180

 
(90,279
)
 
(14.0
)
Other
50,159

 
60,559

 
(10,400
)
 
(17.2
)
Total
$
1,316,462

 
$
1,588,024

 
$
(271,562
)
 
(17.1
)%

 
Operating Profit and Margin
 
 
 
 
 
Quarters Ended
 
 
 
 
 
March 28,
2020
 
March 30,
2019
 
Higher
(Lower)
 
Percent
Change
 
(dollars in thousands)
Innerwear
$
81,551

 
19.3
 %
 
$
104,626

 
22.0
%
 
$
(23,075
)
 
(22.1
)%
Activewear
8,108

 
2.8

 
43,593

 
10.8

 
(35,485
)
 
(81.4
)
International
52,018

 
9.4

 
99,773

 
15.4

 
(47,755
)
 
(47.9
)
Other
(6,125
)
 
(12.2
)
 
754

 
1.2

 
(6,879
)
 
(912.3
)
Corporate
(101,422
)
 
NM

 
(99,102
)
 
NM

 
(2,320
)
 
(2.3
)
Total
$
34,130

 
2.6
 %
 
$
149,644

 
9.4
%
 
$
(115,514
)
 
(77.2
)%
Innerwear  
Innerwear net sales decreased 11% compared to the first quarter of 2019 driven by a 15% and 9% decline in net sales in our intimate apparel and basics businesses, respectively, primarily as a result of the negative impact of the COVID-19 global pandemic. The rapid expansion of COVID-19 in March resulted in a sharp decline in net sales and obscured the turnaround underway in our Innerwear segment as our basics business innovations and intimate apparel business revitalization plans began to show strength across channels through mid-March. In addition, net sales in our Innerwear segment decreased as a result of the exit of the C9 Champion program at Target in 2019.
Innerwear operating margin was 19.3% , representing a decrease from 22.0% in the same period a year ago as a result of lower sales volume, sales mix and higher manufacturing variances caused by decreases in manufacturing facility production levels in our global supply chain due to the business disruption caused by the COVID-19 global pandemic. These decreases were slightly offset by price increases implemented in 2019 and lower variable selling, general and administrative expenses as a result of decreased volume.
Activewear  
Activewear net sales decreased 29% compared to the first quarter last year primarily as a result of the negative impact of the COVID-19 global pandemic. In addition, the exit of the C9 Champion program at Target in 2019 represented approximately $85 million of the net sales decrease in the first quarter of 2020 compared to the first quarter of 2019.
Activewear operating margin was 2.8% , representing a decrease from 10.8% in the same period a year ago. The decrease was a result of sales volume decreases including the exit of the C9 Champion program at Target, sales mix and higher manufacturing variances as a result of decreases in manufacturing facility production levels in our global supply chain due to the business disruption caused by the COVID-19 global pandemic. These decreases were partially offset by lower variable selling, general and administrative expenses as a result of decreased net sales.

29


International
Net sales in the International segment decreased 14% as a result of the negative impact of the COVID-19 global pandemic and the unfavorable impact of foreign currency exchange rates of approximately $20 million. Sales on a constant currency basis, defined as sales excluding the impact of foreign currency, decreased 11%. The impact of foreign exchange rates is calculated by applying prior period exchange rates to the current year financial results.
International operating margin was 9.4% , a decrease from 15.4% in the same period a year ago, primarily due to decreased sales volume particularly in the Asia and Europe activewear businesses where operating margins have historically been higher than in other international businesses and regions.
Other
Other net sales were lower as a result of decreased traffic at our retail outlets due to store closures late in the first quarter of 2020 as a result of the COVID-19 global pandemic and continued declines in hosiery sales in the United States. Operating margin decreased due to the decrease in sales volume at our retail outlets.
Corporate
Corporate expenses included certain administrative costs including restructuring and other action-related charges. Corporate expenses were lower in the first quarter of 2020 compared to the first quarter of 2019 due to lower variable compensation costs partially offset by higher bad debt expense as a result of $11 million of charges for anticipated bankruptcies and higher restructuring and other action-related charges. Supply chain actions include actions to reduce overhead costs. Program exit charges are costs associated with exiting the C9 Champion business with Target and the DKNY Intimates license. Other restructuring costs include action-related costs such as corporate workforce reductions, as well as acquisition and integration charges for smaller acquisitions in 2019.
 
Quarters Ended
 
March 28,
2020
 
March 30,
2019
 
(dollars in thousands)
Restructuring and other action-related charges included in operating profit:

 
 
Supply chain actions
$
14,065

 
$
17,692

Program exit costs
8,215

 

Other restructuring costs
6,919

 
3,681

Total restructuring and other action-related charges included in operating profit
$
29,199

 
$
21,373

Liquidity and Capital Resources
Cash Requirements and Trends and Uncertainties Affecting Liquidity
We rely on our cash flows generated from operations and the borrowing capacity under our credit facilities to meet the cash requirements of our business. The primary cash requirements of our business are payments to our employees and vendors in the normal course of business, capital expenditures, maturities of debt and related interest payments, business acquisitions, contributions to our pension plans, repurchases of our stock, regular quarterly dividend payments and income tax payments. The rapid expansion of the COVID-19 global pandemic has resulted in a sharp decline in net sales and earnings in the first quarter of 2020, which has a corresponding impact on our liquidity. We are focused on preserving our liquidity and managing our cash flow during these unprecedented conditions with preemptive actions to enhance our ability to meet our short-term liquidity needs. Such actions include, but are not limited to, operating our manufacturing and distribution facilities on a demand-adjusted basis; reducing our discretionary spending such as media and marketing expenses; focused working capital management; reducing capital expenditures; suspending our share buyback program until further notice; reducing payroll costs, through employee furloughs and pay cuts; drawing down on our Revolving Loan Facility and amending certain existing debt facilities.

30


In April 2020, given the rapidly changing environment and level of uncertainty being created by the COVID-19 global pandemic and the associated impact on future earnings, we amended our Senior Secured Credit Facility prior to any potential covenant violation in order to modify the financial covenants and to provide operating flexibility during the COVID-19 crisis. The amendment effects changes to certain provisions and covenants under the Senior Secured Credit Facility during the period beginning with the fiscal quarter ending June 27, 2020 and continuing through the fiscal quarter ending July 3, 2021 (such period of time, the “Covenant Relief Period”), including: (a) suspension of compliance with the maximum leverage ratio; (b) reduction of the minimum interest coverage ratio from 3.00 to 1.00 to (i) 2.00 to 1.00 for the fiscal quarters ending June 27, 2020 through April 3, 2021 and (ii) 2.25 to 1.00 for the fiscal quarter ending July 3, 2021; (c) a minimum last twelve months EBITDA covenant of $625 million as of June 27, 2020, $505 million as of September 26, 2020, $445 million as of January 2, 2021, $435 million as of April 3, 2021 and $505 million as of July 3, 2021; (d) a minimum liquidity covenant of $300 million, increasing to $400 million upon certain conditions; (e) increased limitations on investments, acquisitions, restricted payments and the incurrence of indebtedness; and (f) anti-cash hoarding provisions. During the Covenant Relief Period, the applicable margin and applicable commitment fee margin will be calculated assuming the leverage ratio is greater than or equal to 4.50 to 1.00. The amendment also permanently amends the definition of “leverage ratio” for purposes of the financial covenant calculation to remove the maximum amount of cash allowed to be netted from the definition of “indebtedness” and to allow for the netting of cash from certain foreign subsidiaries. After obtaining the debt amendment, we expect to maintain compliance with our covenants for at least one year from the issuance of these financial statements based on our current expectations and forecasts. If economic conditions caused by the COVID-19 global pandemic worsen and our earnings and operating cash flows do not start to recover as currently estimated by us, this could impact our ability to maintain compliance with our amended financial covenants and require us to seek additional amendments to our Senior Secured Credit Facility. If we are not able to obtain such necessary additional amendments, this would lead to an event of default and, if not cured timely, our lenders could require us to repay our outstanding debt. In that situation, we may not be able to raise sufficient debt or equity capital, or divest assets, to refinance or repay the lenders.
We cannot assure you that our assumptions used to estimate our liquidity requirements will remain accurate due to the unprecedented nature of the disruption to our operations and the unpredictability of the COVID-19 global pandemic. As a consequence, our estimates of the duration of the pandemic and the severity of the impact on our future earnings and cash flows could change and have a material impact on our results of operations and financial condition. We believe we have sufficient cash and available borrowings for our foreseeable liquidity needs.
Our primary sources of liquidity are cash generated from global operations and cash available under our Revolving Loan Facility, our Accounts Receivable Securitization Facility and our international loan facilities, including our Australian Revolving Loan Facility and our European Revolving Loan Facility. In March 2020, we drew down $630 million under our Revolving Loan Facility as a precautionary measure, to provide us with additional financial flexibility to manage our business with a safety-first emphasis during the unknown duration and impact of the COVID-19 global pandemic.
We had the following borrowing capacity and availability under our credit facilities as of March 28, 2020 :
 
As of March 28, 2020
Borrowing
Capacity
 
Borrowing
Availability
 
(dollars in thousands)
Senior Secured Credit Facility:
 
 
 
Revolving Loan Facility
$
1,000,000

 
$
45,924

Australian Revolving Loan Facility
36,775

 
5,958

European Revolving Loan Facility
111,359

 

Accounts Receivable Securitization Facility (1)
152,153

 

Other international credit facilities
145,924

 
134,716

Total liquidity from credit facilities
$
1,446,211

 
$
186,598

Cash and cash equivalents
 
 
1,083,780

Total liquidity


 
$
1,270,378

 
 
(1)
Borrowing availability under the Accounts Receivable Securitization Facility is subject to a quarterly fluctuating facility limit, not to exceed $225 million , and permitted only to the extent that the face of the receivables in the collateral pool, net of applicable reserves and other deductions, exceeds the outstanding loans.
The following have impacted or may impact our liquidity:
The negative impact of the COVID-19 global pandemic on our business as discussed above under “Impact of COVID-19 on Our Business”.

31


For the quarter ended March 28, 2020 and prior to the expansion of COVID-19, we entered into transactions to repurchase approximately 14.5 million shares of our common stock at a total cost of $ 200 million. At March 28, 2020 , the remaining repurchase authorization under our current share repurchase program totaled approximately 25.5 million shares. While we may repurchase additional shares of our common stock in the future, the program has been suspended in connection with the amendment to our Senior Secured Credit Facility described above.
We have historically paid a regular quarterly dividend. The declaration of any future dividends and, if declared, the amount of any such dividends, will be subject to our actual future earnings, capital requirements, regulatory restrictions, debt covenants, other contractual restrictions and to the discretion of our Board of Directors.
We have principal and interest obligations under our debt and ongoing financial covenants under those debt facilities, even after taking into account recent amendments.
We have invested in efforts to accelerate worldwide omnichannel and global growth initiatives, as well as marketing and brand building. We anticipate capital expenditures to decrease for the remainder of the year compared to the prior year as we tightly manage spending to help mitigate the potential negative impact of the COVID-19 global pandemic on our business and liquidity.
We expect to continue to invest in efforts to improve operating efficiencies and lower costs.
We may pursue strategic business acquisitions in the future.
We made a contribution of $25 million to our U.S. pension plan in the quarter ended March 28, 2020 . We may also elect to make additional voluntary contributions.
We may increase or decrease the portion of the current-year income of our foreign subsidiaries that we remit to the United States, which could impact our effective income tax rate. Consistent with our investment strategy as it pertains to our historical foreign earnings as of December 28, 2019, we intend to remit historical foreign earnings totaling approximately $1.0 billion.
We are obligated to make installment payments over an eight-year period related to our transition tax liability resulting from the implementation of the Tax Act, which began in 2018, in addition to any estimated income taxes due based on current year taxable income. In the quarters ended March 28, 2020 and March 30, 2019 , we made no installment payments on our transition tax liability and have a remaining balance due of approximately $101 million to be paid in installment payments through 2025.
In March 2020, we drew down $630 million under our Revolving Loan Facility as a precautionary measure to provide us with additional financial flexibility to manage our business with a safety-first emphasis during the unknown duration and impact of the COVID-19 global pandemic. We subsequently repaid $490 million of this borrowing in April 2020.
We are making more than 320 million face masks and expect to make more than 20 million medical gowns for the U.S. government. We are also ramping up production to supply masks to large employers seeking to reopen business operations after being closed as a result of the COVID-19 global pandemic.
We expect the employee furloughs and pay cuts, as well as reductions in discretionary spending such as media and marketing expenses, to save approximately $200 million in 2020.


32


Sources and Uses of Our Cash
The information presented below regarding the sources and uses of our cash flows for the quarters ended March 28, 2020 and March 30, 2019 was derived from our condensed consolidated financial statements.
 
Quarters Ended
 
March 28,
2020
 
March 30,
2019
 
(dollars in thousands)
Operating activities
$
(83,216
)
 
$
(194,291
)
Investing activities
(24,477
)
 
(25,133
)
Financing activities
877,514

 
71,707

Effect of changes in foreign currency exchange rates on cash
(15,061
)
 
2,104

Change in cash, cash equivalents and restricted cash
754,760

 
(145,613
)
Cash, cash equivalents and restricted cash at beginning of year
329,923

 
455,732

Cash, cash equivalents and restricted cash at end of period
1,084,683

 
310,119

Less restricted cash at end of period
903

 
23,039

Cash and cash equivalents per balance sheet at end of period
$
1,083,780

 
$
287,080

Operating Activities
Our overall liquidity has historically been driven by our cash flow provided by operating activities, which is dependent on net income and changes in our working capital, and is subject to certain risks related to the COVID-19 global pandemic. We typically use cash during the first half of the year and generate most of our cash flow in the second half of the year. As compared to the prior year, the lower net cash used by operating activities was due to improved working capital management, specifically related to inventory and accounts receivable. Cash used by operating activities includes a $25 million and a $26 million pension contribution made in the first quarter of 2020 and 2019, respectively.
Investing Activities
Investing activities in the first quarter of 2020 and 2019 primarily include capital investments into our business to support our global growth initiatives. We anticipate capital expenditures to decrease for the remainder of the year compared to the prior year as we tightly manage spending to help mitigate the potential negative impact of the COVID-19 global pandemic on our business and liquidity.
Financing Activities
Net cash from financing activities increased primarily as a result of higher borrowings on our Revolving Loan Facilities in the first quarter of 2020 as compared to the same period of 2019 . We increased our borrowings in the first quarter of 2020 primarily to strengthen our cash position and to provide us with additional financial flexibility to manage our business with a safety-first emphasis during the unknown duration and impact of the COVID-19 global pandemic.
Financing Arrangements
As discussed above, in March 2020, we drew down $630 million under our Revolving Loan Facility to further strengthen our cash position. Additionally, in March 2020 , we amended the Accounts Receivable Securitization Facility. This amendment primarily decreased the fluctuating facility limit to $225 million (previously $300 million) and extended the maturity date to March 2021 .
We believe our financing structure provides a secure base to support our operations and key business strategies. As of March 28, 2020 , we were in compliance with all financial covenants under our credit facilities and other outstanding indebtedness. We continue to monitor our covenant compliance carefully. Under the terms of our Senior Secured Credit Facility, we are required to maintain a minimum interest coverage ratio and a maximum leverage ratio. The interest coverage ratio covenant is the ratio of our EBITDA for the preceding four fiscal quarters to our consolidated total interest expense and the leverage ratio covenant is the ratio of our total debt to EBITDA for the preceding four fiscal quarters. EBITDA is defined as earnings before interest, income taxes, depreciation expense and amortization, as computed pursuant to the Senior Secured Credit Facility. In April 2020, given the rapidly changing environment and level of uncertainty being created by the COVID-19 global pandemic and the associated impact on future earnings, we amended our Senior Secured Credit Facility prior to any potential covenant violation in order to modify the financial covenants and to provide operating flexibility during the COVID-19 crisis. After obtaining the debt amendment discussed above, we expect to maintain compliance with our covenants during the Covenant Relief Period, however economic conditions or the occurrence of events discussed under “Risk Factors” in our Annual Report on Form 10-K for the year ended December 28, 2019 and in this Quarterly Report on Form 10-Q or other SEC filings could cause noncompliance.

33


Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements within the meaning of Item 303(a)(4) of SEC Regulation S-K.
Critical Accounting Policies and Estimates
We have chosen accounting policies that we believe are appropriate to accurately and fairly report our operating results and financial condition in conformity with accounting principles generally accepted in the United States. We apply these accounting policies in a consistent manner. Our significant accounting policies are discussed in Note, “Summary of Significant Accounting Policies,” to our financial statements included in our Annual Report on Form 10-K for the year ended December 28, 2019 .
The application of critical accounting policies requires that we make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosures. These estimates and assumptions are based on historical and other factors believed to be reasonable under the circumstances. We evaluate these estimates and assumptions on an ongoing basis and may retain outside consultants to assist in our evaluation. If actual results ultimately differ from previous estimates, the revisions are included in results of operations in the period in which the actual amounts become known. The critical accounting policies that involve the most significant management judgments and estimates used in preparation of our financial statements, or are the most sensitive to change from outside factors, are discussed in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 28, 2019 . There have been no material changes in these policies from those described in our Annual Report on Form 10-K for the year ended December 28, 2019 .
Recently Issued Accounting Pronouncements
For a summary of recently issued accounting pronouncements, see Note, “Recent Accounting Pronouncements” to our financial statements included in this Quarterly Report on Form 10-Q.
Item 3.
Quantitative and Qualitative Disclosures about Market Risk
There have been no significant changes in our market risk exposures from those described in Item 7A of our Annual Report on Form 10-K for the year ended December 28, 2019 .
Item 4.
Controls and Procedures
Disclosure Controls and Procedures
As required by Exchange Act Rule 13a-15(b), our management, including our Chief Executive Officer and Interim Chief Financial Officer, conducted an evaluation of the effectiveness of our disclosure controls and procedures, as defined in Exchange Act Rule 13a-15(e), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on that evaluation, our Chief Executive Officer and Interim Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of March 28, 2020 due to a material weakness in internal control over financial reporting described in management’s annual report on internal control over financial reporting in our Annual Report on Form 10-K for the year ended December 28, 2019 .
Notwithstanding the identified material weakness, management, including our principal executive officer and principal financial officer have determined, based on the procedures we have performed, that the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q fairly represent in all material respects our financial condition, results of operations and cash flows at March 28, 2020 and for the periods presented in accordance with U.S. GAAP.

34


Remediation Plan for Material Weakness
Management continues to enhance its internal control over financial reporting and to take steps to remediate the material weakness identified during the year ended December 28, 2019 related to income taxes. During the quarter ended  March 28, 2020 , we made progress in our remediation of the control deficiency noted above. In order to remediate the material weakness in our internal controls related to accounting for income taxes, management is enhancing processes and internal controls related to deferred income taxes, effective income tax rate reconciliation and related disclosures. These enhanced controls include documentation evidencing the effective design and operation of annual and quarterly internal controls related to various aspects of deferred taxes and tax rate reconciliation. To assess our remediation progress, during the second quarter of 2020, we plan to test the operating effectiveness of the annual controls by performing our redesigned and enhanced year-end processes using first quarter financial information. These annual and quarterly controls will not be deemed effective until performed effectively for the year ended January 2, 2021. 
We believe the measures described above will remediate the control deficiencies we have identified and strengthen our internal control over financial reporting. We are committed to continuing to improve our internal control processes and will continue to review, optimize and enhance our financial reporting controls and procedures. As we continue to evaluate and work to improve our internal control over financial reporting, we may take additional measures to address control deficiencies, or we may modify certain of the remediation measures described above. The material weakness will not be considered remediated until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively.
Changes in Internal Control over Financial Reporting
In connection with the evaluation required by Exchange Act Rule 13a-15(d), our management, including our Chief Executive Officer and Interim Chief Financial Officer, concluded that no changes in our internal control over financial reporting occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II

Item 1.
Legal Proceedings
Although we are subject to various claims and legal actions that occur from time to time in the ordinary course of our business, we are not party to any pending legal proceedings that we believe could have a material adverse effect on our business, results of operations, financial condition or cash flows.

35


Item 1A.
Risk Factors
In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the risk factors that affect our business and financial results that are discussed in Part I, Item 1A, of our Annual Report on Form 10-K for the fiscal year ended December 28, 2019 . These factors could materially adversely affect our business, financial condition, liquidity, results of operations and capital position, and could cause our actual results to differ materially from our historical results or the results contemplated by the forward-looking statements contained in this report. Other than as set forth below, there have been no material changes to such risk factors.
The novel coronavirus disease (COVID-19) global pandemic has had and is expected to continue to have an adverse impact on our business.
The COVID-19 global pandemic has negatively impacted the global economy, disrupted consumer spending and global supply chains, and created significant volatility and disruption of financial markets. We expect the COVID-19 global pandemic to have a material impact on our business, including our results of operations, financial condition and liquidity. The extent of the impact of the COVID-19 global pandemic on our business, including our ability to execute our near-term and long-term business strategies and initiatives in the expected time frame, will depend on future developments, including the duration and scope of the pandemic, which are uncertain and cannot be predicted, including the effect on our suppliers and disruptions to the global supply chain; our ability to sell and provide our products, including as a result of travel restrictions and people working from home; restrictions or disruptions to transportation, including reduced availability of ground or air transport; and the ability of our customers to pay for our services and products.
As a result of the COVID-19 global pandemic, and in response to government mandates or recommendations made by governmental or other authorities, as well as decisions we have made to protect the health and safety of our employees, consumers and communities, we have temporarily closed our retail stores globally. We may face longer term store closure requirements and other operational restrictions with respect to some or all of our physical locations for prolonged periods of time due to, among other factors, evolving and increasingly stringent governmental restrictions including public health directives, quarantine policies or social distancing measures. In addition, many of our customers, including significant customers in our wholesale distribution channels, have closed many of their stores, which will adversely impact our revenues from these customers. As a result, we expect our financial results to be materially adversely impacted.
We expect the negative impact of the COVID-19 pandemic to lead to continued net sales decreases due to our retail store closures and reduced net sales and earnings for our wholesale customers, some of which may experience financial distress or declare bankruptcy. Reduced retail sales or additional customer store closures and customer bankruptcies could reduce or eliminate our anticipated income and cash flows, which would negatively affect our results of operations and liquidity. Even if customers do not declare bankruptcy, they may seek to extend payment terms or be unable or unwilling to pay us amounts that we are entitled to on a timely basis or at all, which would adversely affect our sales and liquidity.
In addition, consumer fears about becoming ill with the disease may continue, which will adversely affect traffic to our and our customers' stores. Consumer spending generally may also be negatively impacted by general macroeconomic conditions and consumer confidence, including the significant economic downturn, resulting from the COVID-19 global pandemic. This may negatively impact sales in our stores and our e-commerce channel and may cause our wholesale customers to purchase fewer products from us. The continued significant reduction in consumer visits to, and spending at, our and our customers' stores, caused by COVID-19, and any decreased spending at retail stores or online caused by decreased consumer confidence and spending following the pandemic, would result in a loss of sales and profits and other material adverse effects.
The COVID-19 global pandemic also has the potential to significantly impact our supply chain if the factories that manufacture our products, the distribution centers where we manage our inventory, or the operations of our logistics and other service providers are disrupted, temporarily closed or experience worker shortages. We may also see disruptions or delays in shipments and negative impacts to pricing of certain components of our products.
In addition, the impact of COVID-19 on macroeconomic conditions may impact the proper functioning of financial and capital markets, foreign currency exchange rates, commodity prices, and interest rates. Even after the COVID-19 global pandemic has subsided, we may continue to experience adverse impacts to our business as a result of any economic recession or depression that has occurred or may occur in the future.
The continued disruption of global financial markets as a result of the COVID-19 global pandemic could have a negative impact on our ability to access capital in the future.
As a result of the COVID-19 global pandemic, including related guidance or requirements of governmental or other authorities, we also have recently implemented a work from home policy for many of our corporate employees. This policy may negatively impact productivity and cause other disruptions to our business.

36



The extent of the impact of the COVID-19 global pandemic on our business is highly uncertain and difficult to predict, as information is rapidly evolving with respect to the duration and severity of the pandemic.
The COVID-19 global pandemic has disrupted our operations and if we are unable to re-commence normal operations, we may be out of compliance with our required covenants in certain of our debt facilities.
Under the terms of our Senior Secured Credit Facility, we are required to maintain a minimum interest coverage ratio and a maximum leverage ratio. Accordingly, in April 2020, given the impact on our earnings and the rapidly changing environment and level of uncertainty being created by the COVID-19 global pandemic, we amended our Senior Secured Credit Facility prior to any potential covenant violation, in order to modify the financial covenants and to provide operating flexibility during the COVID-19 crisis.
Any additional covenant waivers that may be required may lead to fees associated with obtaining the waiver, increased costs, increased interest rates, additional restrictive covenants and other available lender protections that would be applicable to us under these debt facilities, and such increased costs, restrictions and modifications may vary among debt facilities. In addition, our ability to provide additional lender protections under these facilities if necessary, including the granting of security interests in collateral, will be limited by the restrictions in our debt facilities. There can be no assurance that we would be able to obtain future waivers in a timely manner, on acceptable terms or at all. If we were not able to obtain a covenant waiver under any one or more of these debt facilities, we would be in default of such agreements, which could result in cross defaults to our other debt agreements. As a consequence, we would need to refinance or repay the applicable debt facility or facilities, and would be required to raise additional debt or equity capital, or divest assets, to refinance or repay such facility or facilities. If we were to be unable to obtain a covenant waiver in the future under any one or more of these debt facilities, there can be no assurance that we would be able to raise sufficient debt or equity capital, or divest assets, to refinance or repay such facility or facilities.
With respect to each of our debt facilities, if we were unable to comply with the covenants of any such facilities and were not to obtain a waiver, refinance or repay such debt facilities, it would lead to an event of default under such facilities, which could lead to an acceleration of the indebtedness under such debt facilities. In turn, this would lead to an event of default and potential acceleration of amounts due under all of our outstanding debt and derivative contract payables. As a result, the failure to obtain the covenant waivers described above would have a material adverse effect.

37


Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Repurchases of Equity Securities
The following table sets forth information in connection with purchases made by, or on behalf of, the Company or any affiliate purchaser of the Company, of shares of the Company’s common stock during the quarter ended March 28, 2020 .
 
 
Total Number of Shares Purchased
 
Average
Price Paid
Per Share (1)
 
Total Number of Shares Purchased as Part of Publicly Announced Program
 
Maximum Number of Shares that May Yet Be Purchased under the Program (2)
December 29, 2019 to February 1, 2020
 

 
$

 

 
20,359,607

February 2, 2020 to February 29, 2020
 
12,240,906

 
14.01

 
12,240,906

 
27,759,094

March 1, 2020 to March 28, 2020
 
2,223,424

 
12.82

 
2,223,424

 
25,535,670

Total
 
14,464,330

 
 
 
14,464,330

 
 
(1) Average price paid per share for shares purchased as part of our publicly-announced plan.
(2) On February 6, 2020 , our Board of Directors approved a share repurchase program for up to 40 million shares to be repurchased in open market transactions, subject to market conditions, legal requirements and other factors. Unless terminated earlier by our Board of Directors, the new program will expire when we have repurchased all shares authorized for repurchase under the new program. The new program replaced our previous share repurchase program for up to 40 million shares that was originally approved on April 27, 2016 . We did not repurchase any shares under the previous program during the quarter ended March 28, 2020 .
We net settle our employee stock option exercises and restricted stock unit and performance stock unit vestings, which result in the withholding of shares to cover the option exercise price and the minimum statutory withholding tax obligations that we are required to pay in cash to the applicable taxing authorities on behalf of our employees. We do not consider these transactions to be common stock repurchases.
Item 3.
Defaults Upon Senior Securities
None.
Item 4.
Mine Safety Disclosures
Not applicable.
Item 5.
Other Information
None.

38


Item 6.
Exhibits
Exhibit
Number
 
Description
 
 
 
3.1
 
 
 
 
3.2
 
 
 
 
3.3
 
 
 
 
3.4
 
 
 
 
3.5
 
 
 
 
4.1
 

 
 
 
4.2
 
 
 
 
31.1
 
 
 
 
31.2
 
 
 
 
32.1
 
 
 
 
32.2
 
 
 
 
101.INS XBRL
 
Instance Document - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
 
 
 
101.SCH XBRL
 
Taxonomy Extension Schema Document
 
 
 
101.CAL XBRL
 
Taxonomy Extension Calculation Linkbase Document
 
 
 
101.LAB XBRL
 
Taxonomy Extension Label Linkbase Document
 
 
 
101.PRE XBRL
 
Taxonomy Extension Presentation Linkbase Document
 
 
 
101.DEF XBRL
 
Taxonomy Extension Definition Linkbase Document


39


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.  
HANESBRANDS INC.
 
 
By:
 
/s/ M. Scott Lewis
 
 
M. Scott Lewis
Interim Chief Financial Officer
(Duly authorized officer and principal financial officer)
Date: April 30, 2020

40
Exhibit


Exhibit 4.1
 
DESCRIPTION OF REGISTRANT’S SECURITIES
REGISTERED PURSUANT TO SECTION 12 OF THE
SECURITIES EXCHANGE ACT OF 1934
The following is a summary of the material terms of the securities of Hanesbrands Inc., a Maryland corporation (the “Company”), registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of December 28, 2019, and provisions of the Company’s charter and bylaws. The summary is subject to and qualified in its entirely by reference to the charter and bylaws, each of which is filed as an exhibit to the Annual Report on Form 10-K. The following also summarizes certain provisions of the Maryland General Corporation Law (the “MGCL”) and is subject to and qualified in its entirely by reference to the MGCL.
General
Our charter provides that we may issue up to 2,000,000,000 shares of common stock, par value $0.01 per share, and up to 50,000,000 shares of preferred stock, par value $0.01 per share, and permits our board of directors, without stockholder approval, to amend the charter to increase or decrease the aggregate number of shares of stock or the number of shares of stock of any class or series that we have authority to issue. The MGCL provides that our stockholders are generally not obligated to us or our creditors with respect to our stock, except to the extent that the subscription price or other agreed upon consideration has not been paid.
Common Stock
General.     Holders of our common stock have no preference, conversion, exchange, sinking fund or redemption rights and generally have no appraisal rights. Holders of our common stock are entitled to receive dividends when, as and if authorized by our board of directors and declared by us out of our assets legally available for the payment of dividends. Holders of our common stock are also entitled to share ratably in our assets legally available for distribution to our stockholders in the event of our liquidation, dissolution or winding up, after payment of or adequate provision for all of our known debts and liabilities. These rights are subject to, and may be adversely affected by, the preferential rights granted to any other class or series of our stock, including our preferred stock.

Each outstanding share of our common stock entitles the holder to one vote on all matters submitted to a vote of our stockholders, including the election of directors. Except as provided with respect to any other classes or series of stock, the holders of our common stock will possess exclusive voting power. Pursuant to our bylaws, directors in uncontested elections are elected upon the affirmative vote of a majority of the total votes cast for and against such nominee at a duly called meeting of stockholders. However, under our corporate governance guidelines, if in an uncontested election for director a nominee (whether or not an incumbent) does not receive the affirmative vote of a majority of the total votes cast for and against such nominee, the nominee must offer, following certification of the election results, to submit his or her resignation to our board of directors for consideration. Our governance and nominating committee will make a recommendation to our board of directors as to whether to accept or reject the resignation, taking into account any factors or other information that it considers appropriate and relevant. Directors in contested elections are elected by the affirmative vote of a plurality of the votes cast. In both uncontested and contested elections, holders of shares of our common stock have no right to cumulative voting in the election of directors. Consequently, at each annual meeting of stockholders, the holders of a majority of the shares of our common stock will be able to elect all of our directors.
Under the MGCL, a Maryland corporation generally cannot dissolve, amend its charter, merge or consolidate with, or convert into, another entity, sell all or substantially all of its assets or engage in a statutory share exchange unless advised by its board of directors and approved by the affirmative vote of stockholders entitled to cast at least two-thirds of the votes entitled to be cast on the matter. However, a Maryland corporation may provide in its charter for the approval of these matters by a lesser percentage, as long as such percentage is not less than a majority of all the votes entitled to be cast on the matter. Our charter provides for approval by a majority of all the votes entitled to be cast in these situations, except for certain amendments to our charter relating to the removal of directors.





Holders of our common stock, solely by virtue of their holdings, do not have preemptive rights to subscribe for or purchase any shares of our capital stock which we may issue in the future.
Our common stock is and is expected to remain uncertificated. Therefore, our stockholders will not be able to obtain stock certificates.
Preferred Stock

General.     Our charter authorizes our board of directors to authorize “blank check” preferred stock. Our board of directors can classify and issue from time to time any unissued shares of preferred stock and reclassify any previously classified but unissued shares of any class or series of preferred stock. The applicable terms of a particular class or series of preferred stock will be set forth in the articles supplementary or amendment to our charter establishing such class or series of preferred stock. These terms must include, but are not limited to, some or all of the following:

title of the class or series;
the number of shares of the class or series, which number our board of directors may thereafter increase or decrease;
whether and in what circumstances the holder is entitled to receive dividends and other distributions;
whether (and if so, when and on what terms) the class or series can be redeemed by us or the holder or converted or exchanged by the holder;
whether the class or series will rank senior or junior to or on parity with any other class or series of preferred stock; and
voting and other rights of the class or series, if any.

Unless otherwise described in the articles supplementary or amendment, in the event we liquidate, dissolve or wind up our affairs, the holders of any class or series of preferred stock will have preference over the holders of common stock and any other capital stock ranking junior to such class or series for payment out of our assets of the amount specified in the applicable articles supplementary.
Holders of our preferred stock, solely by virtue of their holdings, do not have preemptive rights to subscribe for or purchase any shares of our capital stock which we may issue in the future.
Certain Provisions of Maryland Law and of Our Charter and Bylaws That Could Have the Effect of Delaying, Deferring or Preventing a Change in Control
Provisions of the MGCL, our charter and bylaws could make the following more difficult:
acquisition of us by means of a tender offer or merger;
acquisition of us by means of a proxy contest or otherwise; or
removal of our incumbent officers and directors.
These provisions, summarized below, are expected to discourage coercive takeover practices and inadequate takeover bids. These provisions also are designed to encourage persons seeking to acquire control of us to first negotiate with our board of directors. We believe that the benefits of the potential ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure our company outweigh the disadvantages of discouraging those proposals because negotiation with such proponent could result in an improvement of their terms.
Board of Directors.     Our charter and bylaws provide that the number of our directors may be established by the board of directors but may not be fewer than the minimum number required by the MGCL (which is currently one) nor more than 25. Pursuant to our charter, we have elected to be subject to the provision of Subtitle 8 of Title 3 of the MGCL regarding the filling of vacancies on our board of directors. Accordingly, except as may be provided by our board of directors in setting the terms of any class or series of stock, including any class or series of preferred stock, any vacancy on our board of directors may be filled only by a majority of the remaining directors, even if the remaining directors do not constitute a quorum, and any director elected to fill a vacancy will serve for the remainder of the full term of the directorship in which such vacancy occurred.
Our board of directors is not currently classified. However, it would be permissible under the MGCL for our board of directors to classify or declassify itself without stockholder approval.
Our charter provides that, subject to the rights of one or more classes or series of preferred stock, a director may be removed from office only for cause (as defined in our charter), and then only by the affirmative vote of at least two-thirds of the votes entitled to be cast generally in the election of directors. For the purpose of the charter, cause means, with respect to any





director, the conviction of a felony or a final judgment of a court of competent jurisdiction holding that such director caused demonstrable, material harm to the corporation through bad faith or active and deliberate dishonesty.
Authority to Issue “Blank Check” Preferred Stock.     The rights of holders of our common stock or preferred stock offered may be adversely affected by the rights of holders of any shares of preferred stock that may be issued in the future. Our board of directors may cause shares of preferred stock to be issued in public or private transactions for any proper corporate purpose. Prior to issuance of shares of each class or series, our board of directors is required under the MGCL and by our charter to set the preferences, conversion or other rights, voting powers, restrictions, limitations as to dividends or other distributions, qualifications and terms or conditions of redemption for each class or series. Shares of preferred stock we issue may have the effect of rendering more difficult or discouraging an acquisition of us deemed undesirable by our board of directors.

Power to Reclassify Shares of Our Common and Preferred Stock.     Our charter also authorizes our board of directors to classify and reclassify any unissued shares of our common stock and preferred stock into other classes or series of capital stock, and permits a majority of our entire board of directors, without stockholder approval, to amend the charter to increase or decrease the aggregate number of shares of capital stock or the number of shares of capital stock of any class or series that we have authority to issue.
We believe that the power to issue additional shares of common stock or preferred stock and to classify or reclassify unissued shares of common stock or preferred stock and thereafter to issue the classified or reclassified shares provides us with increased flexibility in structuring possible future financings and acquisitions and in meeting other needs which might arise. These actions can be taken without stockholder approval, unless stockholder approval is required by applicable law or the rules of any stock exchange or automated quotation system on which our securities may be listed or traded. The New York Stock Exchange currently requires stockholder approval as a prerequisite to listing shares in several instances, including where the present or potential issuance of shares could result in an increase in the number of shares of common stock or in the amount of voting securities outstanding by at least 20%. If the approval of our stockholders is not required for the issuance of our common stock or preferred stock, our board of directors may determine not to seek stockholder approval. Although we have no present intention of doing so, we could issue a class or series of stock that could, depending on the terms of such class or series, have the effect of delaying, deferring or preventing a transaction or a change in control that might involve a premium price for holders of common stock or otherwise be believed to be in the best interest of our stockholders.
Business Combinations.     Under the MGCL, “business combinations” between a Maryland corporation and an interested stockholder or an affiliate of an interested stockholder are prohibited for five years after the most recent date on which the interested stockholder becomes an interested stockholder. These business combinations include certain mergers, consolidations, statutory share exchanges, asset transfers or issuances or reclassifications of equity securities. An interested stockholder is defined as:
any person who beneficially owns 10% or more of the voting power of the corporation’s outstanding voting stock; or
an affiliate or associate of the corporation who, at any time within the two-year period immediately prior to the date in question, was the beneficial owner of 10% or more of the voting power of the then outstanding voting stock of the corporation.
A person is not an interested stockholder under the statute if the board of directors approved in advance the transaction by which the stockholder otherwise would have become an interested stockholder. However, in approving a transaction, the board of directors may provide that its approval is subject to compliance, at or after the time of approval, with any terms or conditions determined by the board.
After the five-year prohibition, any business combination between the corporation and an interested stockholder generally must be recommended by the board of directors of the corporation and approved by the affirmative vote of at least:
80% of the votes entitled to be cast by holders of outstanding shares of voting stock of the corporation; and
two-thirds of the votes entitled to be cast by the holders of voting stock of the corporation other than voting shares held by the interested stockholder with whom or with whose affiliate the business combination is to be effected or held by an affiliate or associate of the interested stockholder.
These super-majority vote requirements do not apply to business combinations in which, among other conditions, the common stockholders receive a minimum price, as defined under Maryland law, for their shares in the form of cash or other consideration in the same form as previously paid by the interested stockholder for its shares.

The statute provides for various exemptions from its provisions, including business combinations that are exempted by the board of directors prior to the time that the interested stockholder becomes an interested stockholder.





The business combination statute could have the effect of delaying, deferring or preventing a transaction or a change in control that might involve a premium price for holders of our common stock or otherwise believed to be in the best interest of our stockholders.
Control Share Acquisitions.     Maryland’s control share acquisition act provides that a holder of “control shares” of a Maryland corporation acquired in a “control share acquisition” has no voting rights with respect to such shares except to the extent approved by a vote of two-thirds of the votes entitled to be cast on the matter. Shares owned by the acquiror, by officers or by directors who are employees of the corporation are excluded from shares entitled to vote on the matter. Control shares are voting shares of stock, which, if aggregated with all other shares of stock owned by the acquiror or in respect of which the acquiror is able to exercise or direct the exercise of voting power (except solely by virtue of a revocable proxy), would entitle the acquiror to exercise voting power in electing directors within one of the following ranges:
one-tenth or more but less than one-third;
one-third or more but less than a majority; or
a majority or more of all voting power.
Control shares do not include shares the acquiring person is then entitled to vote as a result of having previously obtained stockholder approval or shares acquired directly from the corporation. A control share acquisition means the acquisition, directly or indirectly, of ownership of, or the power to direct the exercise of voting power with respect to, outstanding control shares, subject to certain exceptions.
A person who has made or proposes to make a control share acquisition may compel the board of directors of the corporation to call a special meeting of stockholders, to be held within 50 days after a request and written undertaking, to consider the voting rights of the control shares. The right to compel the calling of a special meeting is subject to the satisfaction of certain conditions, including delivery of an acquiring person statement and a written undertaking to pay the expenses of the meeting. If no request for a meeting is made, the corporation may itself present the question at any stockholders meeting.
If voting rights are not approved at the meeting or if the acquiring person does not deliver an “acquiring person statement” as required by the statute, then the corporation may redeem for fair value any or all of the control shares, except those for which voting rights have previously been approved. The right of the corporation to redeem control shares is subject to certain conditions and limitations. Fair value of the control shares is determined, without regard to the absence of voting rights for the control shares, as of the date of the last control share acquisition by the acquiror or, if a meeting of stockholders is held at which the voting rights of the shares are considered and not approved, as of the date of such meeting. If voting rights for control shares are approved at a stockholders meeting and the acquiror becomes entitled to vote a majority of the shares entitled to vote, all other stockholders may elect to exercise appraisal rights.
The fair value of the shares as determined for purposes of appraisal rights may not be less than the highest price per share paid by the acquiror in the control share acquisition.
The control share acquisition statute does not apply to shares acquired in a merger, consolidation or statutory share exchange if the corporation is a party to the transaction, or to acquisitions approved or exempted by the charter or bylaws of the corporation.
Our bylaws contain a provision exempting any and all acquisitions by any person of shares of our stock from Maryland’s control share acquisition act. Our board of directors may, however, amend or eliminate this provision in the future without stockholder approval.
Subtitle 8
Subtitle 8 of Title 3 of the MGCL permits a Maryland corporation with a class of equity securities registered under the Exchange Act and at least three independent directors to elect, by provision in its charter or bylaws or a resolution of its board of directors and notwithstanding any contrary provision in the charter or bylaws, to be subject to any or all of the following five provisions:
a classified board;
a two-thirds vote requirement for removing a director;
a requirement that the number of directors be fixed only by vote of the directors;
a requirement that a vacancy on the board be filled only by a vote of the remaining directors (whether or not they constitute a quorum) and for the remainder of the full term of the class of directors in which the vacancy occurred and until a successor is duly elected and qualifies; or
a majority requirement for the calling of a special meeting of stockholders.





We have elected to be subject to the provision of Subtitle 8 that provides that vacancies on our board of directors may be filled only by the remaining directors (whether or not they constitute a quorum) and that a director elected by the board of directors to fill a vacancy will serve for the remainder of the full term of the directorship. We have not elected to be subject to any of the other provisions of Subtitle 8, including the provisions that would permit us to classify our board of directors without stockholder approval. Through provisions in our charter and bylaws unrelated to Subtitle 8, we (1) vest in our board of directors the exclusive power to fix the number of directors and (2) provide that a director may be removed only for cause (as defined in our charter), and then only by the affirmative vote of two-thirds of the votes entitled to be cast generally in the election of directors.

Amendments to the Charter.     Subject to certain exceptions, our charter may be amended only if declared advisable by the board of directors and approved by the affirmative vote of the holders of not less than a majority of all of the votes entitled to be cast on the matter. Among the exceptions provided for in the charter, the board of directors may, without action by our stockholders, amend our charter to increase or decrease the aggregate number of shares of capital stock or the number of shares of capital stock of any class or series that we have authority to issue, or change the name or designation or par value of any class or series of our capital stock or the aggregate par value. In addition, certain amendments to provisions of our charter relating to removal of directors require the affirmative vote of the holders of not less than two-thirds of all the votes entitled to be cast on the matter.
Advance Notice of Director Nominations and New Business.     Our bylaws provide that with respect to an annual meeting of stockholders, nominations of persons for election to the board of directors and the proposal of other business to be considered by stockholders may be made only:
pursuant to our notice of the meeting;
by or at the direction of the board of directors; or
by a stockholder who is a holder of record both at the time of giving of notice and at the time of the meeting, who is entitled to vote at the meeting in the election of each individual so nominated and who has complied with the advance notice procedures provided for in our bylaws.
In order to comply with the advance notice procedures of our bylaws, stockholders generally must provide notice to our secretary not earlier than the 150th day or later than 5:00 p.m., Eastern Time, on the 120th day before the first anniversary of the date our proxy statement was released for the preceding year’s annual meeting.
With respect to special meetings of stockholders, only the business specified in our notice of the special meeting may be brought before the meeting. Nominations of persons for election to the board of directors at a special meeting may be made only:
by or at the direction of the board of directors; or
provided that the special meeting has been called in accordance with the procedures in our bylaws for stockholder-requested special meetings for the purpose of electing directors, by a stockholder who is a holder of record both at the time of giving of notice and at the time of the meeting, who is entitled to vote at the meeting and who has complied with the advance notice procedures provided for in our bylaws.

Stockholders generally must provide notice to our secretary not earlier than the 120th day before such special meeting or later than 5:00 p.m., Eastern Time, on the later of the 90th day before the special meeting or the tenth day after the first public announcement of the date of the special meeting and the nominees of our board of directors to be elected at the meeting.

A stockholder’s notice must contain certain information specified by our bylaws about the stockholder, its affiliates and any proposed business or nominee for election as a director, including information about the economic interest of the stockholder, its affiliates and any proposed nominee in us.

Special Meetings of Stockholders Pursuant to our bylaws, our chairman, our president, our chief executive officer or our board of directors may call a special meeting of our stockholders. Subject to the provisions of our bylaws, a special meeting of our stockholders to act on any matter that may properly be considered by our stockholders will also be called by our secretary upon the written request of stockholders entitled to cast not less than a twenty percent (20%) of all the votes entitled to be cast at the meeting on such matter, accompanied by the information required by our bylaws. Our secretary will inform the requesting stockholders of the reasonably estimated cost of preparing and delivering the notice of meeting (including our proxy materials), and the requesting stockholder must pay such estimated cost before our secretary may prepare and deliver the notice of the special meeting.
Stockholder Action by Written Consent.     Our bylaws provide that any action required or permitted to be taken at any meeting of our stockholders may be taken without a meeting only by a unanimous consent given in writing or by electronic transmission by each stockholder entitled to vote on the matter or, if the action is advised and submitted to the stockholders for





approval by the board of directors, by a written consent of stockholders entitled to cast not less than the minimum number of votes that would be necessary to take such action at a meeting of stockholders.
Exclusive Forum. Our bylaws provide that, unless we consent in writing to the selection of an alternative forum, the Circuit Court for Baltimore City, Maryland, or, if that court does not have jurisdiction, the United States District Court for the District of Maryland, Northern Division, or the “designated courts,” will be the sole and exclusive forum for (a) any derivative action or proceeding brought on our behalf, (b) any action asserting a claim of breach of any duty owed by any of our current or former directors, officers, employees, stockholders or agents to us or to our stockholders, (c) any action asserting a claim against us or any of our current or former directors, officers, employees, stockholders or agents arising pursuant to any provision of the MGCL or our charter or bylaws or (d) any action asserting a claim against us or any of our current or former directors, officers, employees, stockholders or agents that is governed by the internal affairs doctrine.
If any action containing a cause of action or claim whose subject matter is within the scope of the preceding paragraph is filed in a court other than one of the designated courts in the name of any stockholder (including a beneficial owner) or derivatively on behalf of our company, such stockholder shall be deemed to have consented to: (i) the personal jurisdiction of the designated courts in connection with such action to enforce the preceding sentence; (ii) transfer of such action to the United States District Court for the District of Maryland, Northern Division, if such action was filed in a United States District Court; (iii) dismissal of such action in favor of refiling in the designated courts if such action was filed in a court other than a United States District Court; and (iv) having service of process made upon such stockholder in any such action by service upon such stockholder’s counsel in such action as agent for such stockholder.
Limitation of Liability and Indemnification of Directors and Officers. Maryland law permits a Maryland corporation to include in its charter a provision eliminating the liability of its directors and officers to the corporation and its stockholders for money damages except for liability resulting from actual receipt of an improper benefit or profit in money, property or services or active and deliberate dishonesty that is established by a final judgment and is material to the cause of action. Our charter contains such a provision that eliminates such liability to the maximum extent permitted by Maryland law.
The MGCL requires a Maryland corporation (unless its charter provides otherwise, which our charter does not) to indemnify a director or officer who has been successful, on the merits or otherwise, in the defense of any proceeding to which he or she is made or threatened to be made a party by reason of his or her service in that capacity. The MGCL permits a Maryland corporation to indemnify its present and former directors and officers, among others, against judgments, penalties, fines, settlements and reasonable expenses actually incurred by them in connection with any proceeding to or in which they may be made or are threatened to be made a party or witness by reason of their service in those or other capacities unless it is established that:
the act or omission of the director or officer was material to the matter giving rise to the proceeding and the action was committed in bad faith or was the result of active and deliberate dishonesty;
the director or officer actually received an improper personal benefit in money, property or services; or
in the case of any criminal proceeding, the director or officer had reasonable cause to believe that the act or omission was unlawful.
In addition, under the MGCL, a Maryland corporation may not indemnify a director or officer for an adverse judgment in a suit by or on behalf of the corporation or if the director or officer was adjudged liable on the basis that personal benefit was improperly received, unless, in either case, a court orders indemnification, and then only for expenses. A court may order indemnification for expenses if it determines that the director or officer is fairly and reasonably entitled to indemnification, even though the director or officer did not meet the prescribed standard of conduct or was adjudged liable on the basis that personal benefit was improperly received.
In addition, the MGCL permits a Maryland corporation to advance reasonable expenses to a director or officer upon the corporation’s receipt of:
a written affirmation by the director or officer of his or her good faith belief that he or she has met the standard of conduct necessary for indemnification by the corporation; and
a written undertaking, which may be unsecured, by the director or officer or on his or her behalf to repay the amount paid if it shall ultimately be determined that the standard of conduct was not met.
Our charter authorizes us, and our bylaws obligate us, to the maximum extent permitted by Maryland law in effect from time to time, to indemnify and to pay or reimburse reasonable expenses in advance of final disposition of a proceeding without requiring a preliminary determination of the director’s or officer’s ultimate entitlement to indemnification to:
any present or former director or officer who is made or threatened to be made a party to a proceeding by reason of his or her service in that capacity; or





any individual who, while a director or officer of our company and at our request, serves or has served as a director, officer, partner or trustee of another corporation, partnership, joint venture, trust, employee benefit plan or any other enterprise and who is made or threatened to be made a party to the proceeding by reason of his or her service in that capacity.
Our charter and bylaws also permit us, with the approval of our board of directors, to indemnify and advance expenses to any person who served a predecessor of ours in any of the capacities described above and to any employee or agent of our company or a predecessor of our company.
The Company also maintains indemnity insurance as permitted by Section 2-418 of the MGCL, pursuant to which its officers and directors are indemnified or insured against liability or loss under certain circumstances, which may include liability or related losses under the Securities Act of 1933, as amended, or the Exchange Act.



Exhibit
Exhibit 4.2

SUPPLEMENTAL INDENTURE
SUPPLEMENTAL INDENTURE No. 9 (this “ Supplemental Indenture ”), dated as of April 14, 2020, between Hanesbrands Finance Luxembourg S.C.A., a corporate partnership limited by shares ( société en commandite par actions ) incorporated under the laws of the Grand Duchy of Luxembourg having its registered office at 33, Rue du Puits Romain, L-8070 Betrange, Grand Duchy of Luxembourg, and registered with the Luxembourg register of commerce and companies under the number B 206.211, as the issuer (such company, and its successors and assigns under the Indenture hereinafter referred to, being herein called the “ Issuer ”), Hanesbrands (HK) Limited, incorporated under the laws of Hong Kong (“ Hanesbrands HK ”), Hanesbrands Korea LLC, a limited liability company organized under the laws of Korea (Hanesbrands Korea and, together with Hanesbrands HK the “ Additional Guarantors ”) and U.S. Bank Trustees Limited, as trustee (the “ Trustee ”).
W I T N E S S E T H
WHEREAS, the Issuer has heretofore executed and delivered to the Trustee an indenture, dated as of June 3, 2016 (the “ Indenture ”) providing for the issuance of the Issuer’s euro denominated 3.5% Senior Notes due 2024 (the “ Senior Notes ”);
WHEREAS, the Indenture provides that under certain circumstances each Additional Guarantor may execute and deliver to the Trustee a supplemental indenture pursuant to which each such entity shall fully and unconditionally guarantee all of the Issuer’s obligations under the Senior Notes and the Indenture on the terms and conditions set forth herein and under the Indenture (each an “ Additional Notes Guarantee ” and together the “ Additional Notes Guarantees ”);
WHEREAS, the Issuer has heretofore executed and delivered to the Trustee eight supplemental indentures, dated as of June 23, 2016, November 9, 2016, November 9, 2016, March 28, 2017, February 20, 2018, August 24, 2018, October 1, 2018 and November 30, 2018 respectively, pursuant to which certain of the Issuer’s subsidiaries provided Additional Notes Guarantees; and
WHEREAS, pursuant to Section 9.01 of the Indenture, the Issuer, the Additional Guarantors and the Trustee are authorized to execute and deliver this ninth Supplemental Indenture without the consent of the holders of the Senior Notes.
NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Issuer, each of the Additional Guarantor and the Trustee mutually covenant and agree for the equal and ratable benefit of the Holders as follows:
1. CAPITALIZED TERMS. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.
2. AGREEMENT TO GUARANTEE. Each Additional Guarantor hereby agrees to provide an unconditional Additional Notes Guarantee on the terms and subject to the conditions set forth in this Supplemental Indenture and the Indenture including but not limited to Article X thereof (and including the guarantee limitations set out therein).
3. NO RECOURSE AGAINST OTHERS. No past, present or future director, officer, manager, employee, incorporator or stockholder of any Additional Guarantor, as such, shall have any liability for any obligations of the Issuer or any Additional Guarantor under the Indenture, the Senior Notes, the Additional Notes Guarantees or this Supplemental Indenture or for any claim based on, in respect of, or by reason of, such obligations or their creation. Each Holder by accepting a Senior Note waives and releases all such liability. The waiver and release are part of the consideration for issuance of the Senior Notes.
4. THE INTERNAL LAW OF THE STATE OF NEW YORK SHALL GOVERN AND BE USED TO CONSTRUE THIS SUPPLEMENTAL INDENTURE, THE SENIOR NOTES AND THE ADDITIONAL NOTES GUARANTEES, WITHOUT GIVING EFFECT TO APPLICABLE PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE REQUIRED THEREBY.
5. Each of the parties hereto irrevocably agrees that any suit, action or proceeding arising out of, related to, or in connection with the Indenture, this Supplemental Indenture, the Senior Notes and the Additional Notes Guarantees or the transactions contemplated hereby, and any action arising under U.S. federal or state securities laws, may be instituted in any U.S. federal or state court located in the State and City of New York, Borough of Manhattan; irrevocably waives, to the fullest extent it may effectively do so, any objection which it may now or hereafter have to the laying of venue of any such proceeding; and irrevocably submits to the jurisdiction of such courts in any such suit, action or proceeding. Each of the Issuer and the Additional Guarantor expressly consents to the jurisdiction of any such court in respect of any such action and waives any other requirements of or objections to personal jurisdiction with respect thereto and waives any right to trial by jury.
6. COUNTERPARTS. The parties may sign any number of copies of this Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement.
7. EFFECT OF HEADINGS. The Section headings herein are for convenience only and shall not affect the construction hereof.
8. THE TRUSTEE. The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Supplemental Indenture, the Additional Notes Guarantees of the Additional Guarantors or for or in respect of the recitals contained herein, all of which recitals are made solely by each Additional Guarantor and the Issuer. All of the provisions contained in the Indenture in respect of the rights, privileges, immunities, powers and duties of the Trustee shall be applicable in respect of this Supplemental Indenture as fully and with like force and effect as though fully set forth in full herein.
(Signature Pages Follow)

IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed and attested, all as of the date first above written.

HANESBRANDS FINANCE LUXEMBOURG S.C.A. , as the Issuer
By Hanesbrands GP Luxembourg S.à r.l., its general partner

/s/ M. Scott Lewis            
Name: M. Scott Lewis
Title: Class A Manager


/s/ Robert H. Hessing                    
Name: Robert H. Hessing
Title: Class B Manager

HANESBRANDS (HK) LIMITED , as Additional Guarantor

By:     /s/ M. Scott Lewis            
Name: M. Scott Lewis
Title: Director

HANESBRANDS KOREA LLC , as Additional Guarantor


By:     /s/ M. Scott Lewis            
Name: M. Scott Lewis
Title: Director


U.S. BANK TRUSTEES LIMITED , as Trustee

By:     /s/ Laurence Griffiths        
Name: Laurence Griffiths
Title: Authorized Signatory


By:     /s/ Chris Hobbs            
Name: Chris Hobbs
Title: Authorized Signatory


NAI-1512419707v4
Exhibit
Exhibit 31.1

CERTIFICATION PURSUANT TO
SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002
I, Gerald W. Evans, Jr. , certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Hanesbrands Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/ Gerald W. Evans, Jr.
Gerald W. Evans, Jr.
Chief Executive Officer
Date: April 30, 2020

Exhibit
Exhibit 31.2

CERTIFICATION PURSUANT TO
SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002
I, M. Scott Lewis , certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Hanesbrands Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/ M. Scott Lewis
M. Scott Lewis
Interim Chief Financial Officer
Date: April 30, 2020


Exhibit
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Hanesbrands Inc. (“Hanesbrands”) on Form 10-Q for the fiscal quarter ended March 28, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Gerald W. Evans, Jr. , Chief Executive Officer of Hanesbrands, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Hanesbrands.

/s/ Gerald W. Evans, Jr.
Gerald W. Evans, Jr.
Chief Executive Officer

Date: April 30, 2020
The foregoing certification is being furnished to accompany Hanesbrands Inc.’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 28, 2020 (the “Report”) solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed as part of the Report or as a separate disclosure document and shall not be deemed incorporated by reference into any other filing of Hanesbrands Inc. that incorporates the Report by reference. A signed original of this written certification required by Section 906 has been provided to Hanesbrands Inc. and will be retained by Hanesbrands Inc. and furnished to the Securities and Exchange Commission or its staff upon request.


Exhibit
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Hanesbrands Inc. (“Hanesbrands”) on Form 10-Q for the fiscal quarter ended March 28, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, M. Scott Lewis , Interim Chief Financial Officer of Hanesbrands, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Hanesbrands.

/s/ M. Scott Lewis
M. Scott Lewis
Interim Chief Financial Officer

Date: April 30, 2020
The foregoing certification is being furnished to accompany Hanesbrands Inc.’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 28, 2020 (the “Report”) solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed as part of the Report or as a separate disclosure document and shall not be deemed incorporated by reference into any other filing of Hanesbrands Inc. that incorporates the Report by reference. A signed original of this written certification required by Section 906 has been provided to Hanesbrands Inc. and will be retained by Hanesbrands Inc. and furnished to the Securities and Exchange Commission or its staff upon request.


Minimum 15 minutes delayed. Source: LSEG